<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="nar" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC2910057/" /><meta name="ncbi_app" content="pmc" />
        <!-- Logger end -->
        
        <title>Identification and validation of the pathways and functions regulated by the orphan nuclear receptor, ROR alpha1, in skeletal muscle</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910057/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Nucleic Acids Research" /><meta name="citation_title" content="Identification and validation of the pathways and functions regulated by the orphan nuclear receptor, ROR alpha1, in skeletal muscle" /><meta name="citation_authors" content="S. Raichur, R. L. Fitzsimmons, S. A. Myers, M. A. Pearen, P. Lau, N. Eriksson, S. M. Wang, G. E. O. Muscat" /><meta name="citation_date" content="July 2010" /><meta name="citation_issue" content="13" /><meta name="citation_volume" content="38" /><meta name="citation_firstpage" content="4296" /><meta name="citation_doi" content="10.1093/nar/gkq180" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC2910057/?report=abstract" /><meta name="citation_pmid" content="20338882" /><meta name="DC.Title" content="Identification and validation of the pathways and functions regulated by the orphan nuclear receptor, ROR alpha1, in skeletal muscle" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Oxford University Press" /><meta name="DC.Contributor" content="S. Raichur" /><meta name="DC.Contributor" content="R. L. Fitzsimmons" /><meta name="DC.Contributor" content="S. A. Myers" /><meta name="DC.Contributor" content="M. A. Pearen" /><meta name="DC.Contributor" content="P. Lau" /><meta name="DC.Contributor" content="N. Eriksson" /><meta name="DC.Contributor" content="S. M. Wang" /><meta name="DC.Contributor" content="G. E. O. Muscat" /><meta name="DC.Date" content="2010 Jul" /><meta name="DC.Identifier" content="10.1093/nar/gkq180" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Identification and validation of the pathways and functions regulated by the orphan nuclear receptor, ROR alpha1, in skeletal muscle" /><meta property="og:type" content="article" /><meta property="og:description" content="The retinoic acid receptor-related orphan receptor (ROR) alpha has been demonstrated to regulate lipid metabolism. We were interested in the RORα1 dependent physiological functions in skeletal muscle. This major mass organ accounts for ∼40% ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910057/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.9.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.9.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'/pmc/utils/ctxp/'" /><script type="text/javascript" src="/corehtml/pmc/ctxp/jquery.citationexporter.js">//</script><link rel="stylesheet" href="/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-nar.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC2910057/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC2910057/pdf/gkq180.pdf" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="F4FC690BB4D241A100000000005C0051.m_8" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>
    <body class="article">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br />
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="clone">Clone</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="nucest">EST</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="nucgss">GSS</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="pubmedhealth">PubMed Health</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option><option value="unigene">UniGene</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="archive"><a class="navlink" href="/pmc/journals/4/">Nucleic Acids Res</a></li><li class="issue-page"><a class="navlink" href="/pmc/issues/188806/">v.38(13); 2010 Jul</a></li><li class="accid">PMC2910057</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/narlogo.gif" alt="Logo of nar" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher's site" title="Link to Publisher's site" shape="default" coords="0,0,499,74" href="http://academic.oup.com/nar" target="pmc_ext" ref="reftype=publisher&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" /></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="small"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">Nucleic Acids Res</span>. 2010 Jul; 38(13): 4296–4312. </span></div><div><span class="fm-vol-iss-date">Published online 2010 Mar 24. </span>  <span class="doi">doi:  <a href="//dx.doi.org/10.1093%2Fnar%2Fgkq180" target="pmc_ext" ref="reftype=other&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">10.1093/nar/gkq180</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC2910057</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/20338882">20338882</a></div></div></div></div></div><h1 class="content-title">Identification and validation of the pathways and functions regulated by the orphan nuclear receptor, ROR alpha1, in skeletal muscle</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Raichur%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20338882">S. Raichur</a>, <a href="/pubmed/?term=Fitzsimmons%20RL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20338882">R. L. Fitzsimmons</a>, <a href="/pubmed/?term=Myers%20SA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20338882">S. A. Myers</a>, <a href="/pubmed/?term=Pearen%20MA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20338882">M. A. Pearen</a>, <a href="/pubmed/?term=Lau%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20338882">P. Lau</a>, <a href="/pubmed/?term=Eriksson%20N%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20338882">N. Eriksson</a>, <a href="/pubmed/?term=Wang%20SM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20338882">S. M. Wang</a>, and  <a href="/pubmed/?term=Muscat%20GE%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20338882">G. E. O. Muscat</a><sup>*</sup></div><div style="display:none" class="contrib-group aff-tip"></div></div><div class="fm-panel small half_rhythm"><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140662069576128_ai" style="display:none"><div class="fm-affl" lang="en" id="idm140662074093728">The University of Queensland, Institute for Molecular Bioscience, Brisbane, Queensland, 4072, Australia</div><div id="COR1">*To whom correspondence should be addressed. Tel: +61 7 3346 22222; Fax: +61 7 3346 2101; Email: <a href="mailto:dev@null" data-email="ua.ude.qu.bmi@tacsum.g" class="oemail">ua.ude.qu.bmi@tacsum.g</a></div><div id="idm140662147441568">Present address: S. Raichur, Lilly Singapore Centre for Drug Discovery, 8A Biomedical Grove #02-05, Immunos, 138648, Singapore.</div><div id="idm140662147894064">The authors wish it to be that, in their opinion, the first three authors should be regarded as joint First Authors.</div></div><div class="togglers"><a href="#" class="pmctoggle" rid="idm140662069576128_ai">Author information <span>►</span></a> <a href="#" class="pmctoggle" rid="idm140662069576128_an">Article notes <span>►</span></a> <a href="#" class="pmctoggle" rid="idm140662069576128_cpl">Copyright and License information <span>►</span></a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm140662069576128_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2009 Dec 2; Revised 2010 Feb 25; Accepted 2010 Mar 2.</div></div><div class="fm-cpl-info fm-panel hide half_rhythm" id="idm140662069576128_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; The Author(s) 2010. Published by Oxford University Press.</div><div class="fm-copyright half_rhythm"><div class="license">This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<a href="http://creativecommons.org/licenses/by-nc/2.5" ref="reftype=extlink&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">http://creativecommons.org/licenses/by-nc/2.5</a>), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</div></div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="small"><div>This article has been <a href="/pmc/articles/PMC2910057/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="idm140662067708432" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140662067708432title" style="text-transform: uppercase;">Abstract</h2><!--article-meta--><div><p id="__p3" class="p p-first-last">The retinoic acid receptor-related orphan receptor (ROR) alpha has been demonstrated to regulate lipid metabolism. We were interested in the ROR&#x003b1;1 dependent physiological functions in skeletal muscle. This major mass organ accounts for &#x0223c;40% of the total body mass and significant levels of lipid catabolism, glucose disposal and energy expenditure. We utilized the strategy of targeted muscle-specific expression of a truncated (dominant negative) ROR&#x003b1;1&#x00394;DE in transgenic mice to investigate ROR&#x003b1;1 signaling in this tissue. Expression profiling and pathway analysis indicated that ROR&#x003b1; influenced genes involved in: (i) lipid and carbohydrate metabolism, cardiovascular and metabolic disease; (ii) LXR nuclear receptor signaling and (iii) Akt and AMPK signaling. This analysis was validated by quantitative PCR analysis using TaqMan low-density arrays, coupled to statistical analysis (with Empirical Bayes and Benjamini&#x02013;Hochberg). Moreover, westerns and metabolic profiling were utilized to validate the genes, proteins and pathways (lipogenic, Akt, AMPK and fatty acid oxidation) involved in the regulation of metabolism by ROR&#x003b1;1. The identified genes and pathways were in concordance with the demonstration of hyperglycemia, glucose intolerance, attenuated insulin-stimulated phosphorylation of Akt and impaired glucose uptake in the transgenic heterozygous Tg-ROR&#x003b1;1&#x00394;DE animals. In conclusion, we propose that ROR&#x003b1;1 is involved in regulating the Akt2-AMPK signaling pathways in the context of lipid homeostasis in skeletal muscle.</p></div></div><div id="__sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec1title" style="text-transform: uppercase;">INTRODUCTION</h2><p id="__p4" class="p p-first">Retinoic acid receptor related orphan receptor alpha (ROR&#x003b1;) is an orphan member of the nuclear receptor superfamily of transcription factors. Several <em>in vitro</em> and <em>in vivo</em> studies on ROR&#x003b1; action and function (<a href="#B1" rid="B1 B2 B3 B4 B5" class=" bibr popnode">1&#x02013;5</a>) have suggested the involvement of this orphan nuclear receptor in lipid homeostasis (<a href="#B6" rid="B6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115720">6</a>) and hepatic phase I/II metabolism (<a href="#B7" rid="B7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115678">7</a>). ROR&#x003b1; can be detected in many metabolic tissues including liver, kidney, adipose tissue and is highly expressed in skeletal muscle. In mice, ROR&#x003b1; deficiency leads to profound metabolic disturbances. The homozygous staggerer (sg/sg) mice have a global ROR&#x003b1; defect that results in decreased and dysfunctional expression of both mouse isoforms of ROR&#x003b1; (1 and 4). These mice display hypoalphalipoproteinemia, dyslipidemia (decreased serum triglycerides and HDL-cholesterol) (<a href="#B5" rid="B5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115726">5</a>), susceptibility to atherosclerosis (<a href="#B2" rid="B2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115716">2</a>) and reduced adiposity and resistance to diet-induced obesity (<a href="#B8" rid="B8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115662">8</a>). The complex phenotype of the staggerer mice has been demonstrated to involve underlying changes in the expression of genes involved in fatty acid homeostasis, i.e. Apo-lipoprotein A1 (ApoA1) (<a href="#B5" rid="B5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115721">5</a>), Apo-lipoprotein C3 (ApoCIII) (<a href="#B1" rid="B1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115689">1</a>), sterol regulatory element-binding protein 1c (SREBP-1c), ATP-binding cassette transporter-binding proteins A1 and G1 (ABCA1 and G1), peroxisome proliferator-activated receptor gamma co-activator alpha/beta (PGC-1&#x003b1;/&#x003b2;), lipin1 and beta2-adrenergic receptor (<a href="#B8" rid="B8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115738">8</a>).</p><p id="__p5">In the context of whole body metabolism, skeletal muscle has a vital contribution to the maintenance of energy balance. It is a major mass peripheral tissue with high energy demands. Consequently, multiple metabolic pathways converge in this tissue involving the utilization of both lipid and carbohydrate substrates. Skeletal muscle is considered a major site of glucose disposal and perturbation of insulin-mediated glucose uptake in this tissue is an important factor in the development of type 2 diabetes. In addition, the development of insulin resistance in skeletal muscle has been associated with increased intramuscular triglyceride accumulation, which can attenuate several insulin signaling pathways (<a href="#B9" rid="B9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115736">9</a>). As type 2 diabetes and associated complications are health issues that have global significance, it is therefore of considerable interest to investigate the regulatory machinery responsible for maintaining tight metabolic control in this tissue.</p><p id="__p6" class="p p-last">Previously, our analysis of skeletal muscle from staggerer mice (<a href="#B8" rid="B8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115681">8</a>) identified differential expression of a number of genes involved in fatty acid homeostasis. In this study, we aimed to investigate the role of ROR&#x003b1; in skeletal muscle, without the complex interactions that result from the global defect. Therefore, we generated a transgenic mouse that overexpressed truncated human ROR&#x003b1;1&#x00394;DE (lacking the ligand-binding domain) in skeletal muscle to investigate the contribution of this energy demanding tissue to the ROR&#x003b1; phenotype. We used a three-pronged genomic approach, utilizing llumina expression profiling, Ingenuity function and pathway analysis, and validation by rigorous quantitative PCR (qPCR) analysis on the TaqMan&#x000ae; low density array (TLDA) platform. This demonstrated that ROR&#x003b1; has an important role in the regulation of carbohydrate and lipid metabolism in skeletal muscle. In particular, this animal model demonstrated that ROR&#x003b1;1 also plays a critical role in skeletal muscle insulin signaling and glucose tolerance, via modulation of Akt2 and adenosine monophosphate kinase (AMPK) expression and activity. This correlated with increased expression of phospho ACC and genes involved in the regulation of fatty acid oxidation. In conclusion, we propose that in skeletal muscle ROR&#x003b1;1 is an important metabolic regulator, contributing to both glucose and fatty acid homeostasis.</p></div><div id="__sec2" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec2title" style="text-transform: uppercase;">MATERIALS AND METHODS</h2><div id="__sec3" class="sec sec-first"><h3>Production of transgenic-mouse</h3><p id="__p7" class="p p-first-last">The transgenic vector construct encodes a truncated version of human ROR&#x003b1;1 (ROR&#x003b1;1&#x00394;DE). Amino acids 1&#x02013;235 are present but the entire E region and part of the hinge/D region have been removed as previously described (<a href="#B3" rid="B3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115740">3</a>). To confer muscle specificity, the vector was placed under the control of the full-length human skeletal alpha-actin (HSA) promoter as described previously (<a href="#B10" rid="B10 B11 B12" class=" bibr popnode">10&#x02013;12</a>). Zygotes were generated by pronuclear microinjection of the transgene into oocytes from hybrid female donors (C57BL/6J X CBA) as described (<a href="#B13" rid="B13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115663">13</a>). Screening of founder mice and their offspring for stable germ line transmission was performed by real time PCR. The sequences of the specific mouse ROR&#x003b1; and human ROR&#x003b1; primers were as follows&#x02014;hROR&#x003b1;: CAATGCCACCTACTCCTGTCC and CTACGGCAAGGCATTTCTGTAAT, mROR&#x003b1;: CAATGCCACCTACTCCTGTCC and GCCAGGCATTTCTGCAGC. Transgene copy number was determined using real time PCR as described (<a href="#B14" rid="B14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115669">14</a>). Two founders were selected for analysis, each of which carried two copies of the transgene. Both lines were then backcrossed with C57Bl/6J mice for a minimum of five generations. Experiments were performed on transgenic mice from the fifth generation onward, relative to wt littermates; therefore the genetic background of the animals in this study is &#x0003e;98.6% C57Bl/6J. The initial characterization was performed on both transgenic lines. No differences were observed in either phenotype or metabolic gene expression between the two lines, therefore we continued investigation on one line only.</p></div><div id="__sec4" class="sec"><h3>Animal procedures</h3><p id="__p8" class="p p-first-last">The mice were housed in the QBP vivarium (University of Queensland, St. Lucia, Queensland, Australia) with 12 h light&#x02013;dark cycle and fed a standard diet containing 4.6% total fat (from Specialty Feeds, Glen Forrest, Western Australia). For the diet-induced obesity experiments, mice were transferred to a high-fat diet containing 34.9% fat (<a id="__tag_362115851" class="tag_hotlink" href="/nuccore/D12492" ref="/nuccore/D12492"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"D12492","term_id":"220376","term_text":"D12492"}}</span>D12492</a>, Research Diets, New Brunswick, NJ) from 4 weeks of age onward. Experimental animals were weighed weekly up to 14 weeks of age. Mice were fasted overnight by transferring to a new food-free holding cage with unrestricted access to water, prior to all experimental procedures. Care was taken to euthanize all animals at 9 am (i.e. 3 h into the light cycle, and at similar times), and excised tissues were immediately frozen in liquid nitrogen and then stored at &#x02212;80&#x000b0;C. All aspects of animal experimentation were approved by The University of Queensland Animal Ethics Committee.</p></div><div id="__sec5" class="sec"><h3>Microarray analysis</h3><p id="__p9" class="p p-first-last">It is completely described in <a href="http://nar.oxfordjournals.org/cgi/content/full/gkq180/DC1" ref="reftype=extlink&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">Supplementary Figure S1</a>.</p></div><div id="__sec6" class="sec"><h3>RNA extraction, cDNA synthesis and qPCR TLDA analysis</h3><p id="__p10" class="p p-first-last">Total RNA extraction and cDNA synthesis were performed as described previously (<a href="#B4" rid="B4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115712">4</a>). We utilized custom designed ABI microfluidic TLDAs to analyze the expression of genes involved in metabolism (lipid, carbohydrate and energy homeostasis). Three control genes were utilized, including the mandatory control (18S rRNA) and four other controls: Gapdh, GusB, Hprt1 and 36B4. These controls span the relative abundance/Ct range of the genes on the card, and three (18S rRNA, GAPDH and 36b4) are approved real time PCR controls for NURSA supported nuclear receptor studies (<a href="#B15" rid="B15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115676">15</a>,<a href="#B16" rid="B16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115708">16</a>). The TLDAs were analyzed as described in Myers <em>et al.</em> (<a href="#B17" rid="B17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115709">17</a>). Briefly, significant changes in expression relative to wt littermate mice were analyzed using the ABI/integromics &#x02018;StatMiner&#x02019; software package. Differentially expressed genes were identified by linear models (contained in the LIMMA package for bioconductor R embedded in StatMiner). Significance was assigned by the application of the Empirical Bayes statistic. B values represent the empirical bayes log odds of differential expression, and the <em>t</em>-value is the empirical bayes moderated t-statistic. Subsequently, we applied a more stringent/conservative data filtering (Benjamini&#x02013;Hochberg) to control for false discovery rate, correct <em>P</em> values and further refine the subset of differentially expressed genes.</p></div><div id="__sec7" class="sec"><h3>Primers and qPCR</h3><p id="__p11" class="p p-first-last">Relative expression of genes was determined using the ABI 7500 real time PCR System (ABI, Singapore) as previously described (<a href="#B3" rid="B3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115685">3</a>). Primers for LXR&#x003b1;, GAAATGCCAGGAGTGTCGAC and GATCTGTTCTTCTGACAGCACACA; Akt1, GGCTGGCTGCACAAACG and GACTCTCGCTGATCCACATCCT; Akt3, CCTTCCAGACAAAAGACCGTTT and CGCTCTCTCGACAAATGGAAA; GLUT1, TACGCTGGAGGCGGTAGCT and AATGGGCGAATCCTAAAATGG.</p></div><div id="__sec8" class="sec"><h3>Protein extraction</h3><p id="__p12" class="p p-first-last">Total soluble protein was extracted from skeletal muscle (quadriceps) by the addition of lysis buffer (10 mM Tris (pH 8.0), 150 mM NaCl, 1% Triton X-100 and 5 mM EDTA) containing protease and phosphatase &#x02018;cocktail&#x02019; inhibitors (Roche diagnostics GmbH, Mannheim, Germany). Lysates were passed through a 26-gauge needle and centrifuged at 10 000<em>g</em> for 20 min. The supernatant was collected and total protein concentration was determined by the bicinchoninic acid (BCA assay kit), as outlined by manufacturer&#x02019;s instructions (Pierce Biotechnology Inc., Rockford, IL, USA).</p></div><div id="__sec9" class="sec"><h3>Glucose and insulin tolerance tests and glucose uptake</h3><p id="__p13" class="p p-first-last">Basal glucose measurements were obtained from the tail blood of overnight fasted animals (14&#x02013;16 weeks of age). Mice were then administered a dose of either glucose solution (2 g/kg) or insulin (0.5 U/kg) by intraperitoneal injection. Blood glucose measurements were obtained at 10 or 15 min intervals for up to 90 min following challenge using the Accu-Chek Performa blood glucose testing system (Roche Diagnostics Australia, Castle Hill, NSW). Plasma insulin measurements were obtained using the insulin (mouse) Ultrasensitive EIA (ALPCO Diagnostics, Salem NH). Insulin-stimulated glucose uptake was performed on skeletal muscle (extensor digitorum longus, EDL) dissected from anesthetized mice and incubated in essential buffer (Krebs&#x02013;Henseleit, pH 7.4) and the assay was performed as described previously (<a href="#B18" rid="B18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115728">18</a>,<a href="#B19" rid="B19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115701">19</a>).</p></div><div id="__sec10" class="sec"><h3>Western blot analysis</h3><p id="__p14" class="p p-first-last">Total soluble protein from the quadriceps of transgenic and their littermate wild-type mice were resolved on a 10% SDS&#x02013;PAGE gel and transferred to a PVDF (Millipore Corporation, Billerica, MA, USA). The membranes were blocked for 1 h in 5% BSA in TBS&#x02013;Tween 20, followed by an overnight incubation with primary antibody. The following antibodies were purchased from Cell Signaling Technology, Danvers, MA and used at 1:1000 dilution: AMPK&#x003b1; (#2532), pAMPK (Thr172) (#2535), Akt (#9272), pAKT (ser473) (#4058), ACC (#3662) and pACC(Ser79) (#3661). Anti-GAPDH (1:10000) was from R&#x00026;D Systems, Minneapolis, MN. Following 3 &#x000d7; 10 min washes, the membrane was incubated with anti-rabbit horseradish peroxidase (HRP) (1:10000) for 1 h. Immunoreactive signals were detected using enhanced chemiluminescence Super Signal West Pico Substrate (Pierce) and visualized by autoradiography on an X-OMAT film developer (Kodak).</p></div><div id="__sec11" class="sec"><h3>Chromatin immunoprecipitation analysis</h3><p id="__p15" class="p p-first-last">C2C12 cells were differentiated for 4 days. Cells were harvested and subsequently washed twice in ice cold PBS and cross-linked in 1% formaldehyde solution. Chromatin immunoprecipitation (ChIP) was performed as described by Pearen <em>et al.</em> (<a href="#B20" rid="B20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115671">20</a>) using anti-ROR&#x003b1; (Santa Cruz anti-ROR&#x003b1; sc-6062) and IgG (Santa Cruz, CA). The following qPCR ChIP primers were used: RORRE Site 1 F&#x02014;GCATGTGCTGCAAACATTCAG (&#x02212;2897 to &#x02212;2876), R&#x02014;CTACACAGGGTCAGTGGCCA (&#x02212;2866 to &#x02212;2846). RORE Site 2 F&#x02014;GAACATGAAGATTTGAACTTG (&#x02212;2705 to &#x02212;2684), R&#x02014;CTGACCCAGAAACTCCTACA (&#x02212;2668 to &#x02212;2649). RORRE Site 3 F&#x02014;CTGGGTCAGTAGAGTAGCAAGCC (&#x02212;2657 to 2634), R&#x02014;TAAGCATTCTGAGGTGACCTATGAA (&#x02212;2631 to 2606). Downstream Negative control F&#x02014;GTTCCCAAGTGAAGAACCGC (&#x02212;278 to &#x02212;258), R&#x02014;CCGGCAATCAAAGGGCTT (&#x02212;195 to &#x02212;177).</p></div><div id="__sec12" class="sec sec-last"><h3>Statistical analysis</h3><p id="__p16" class="p p-first-last">The TLDA gene expression data were analyzed as described above. All other results were analyzed (and significance assigned) using a <em>t</em>-test, or ANOVA in the Graphpad Prism 4 software, unless otherwise indicated.</p></div></div><div id="__sec13" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec13title" style="text-transform: uppercase;">RESULTS</h2><div id="__sec14" class="sec sec-first"><h3>Overexpression of truncated ROR&#x003b1;1&#x00394;DE (lacking the ligand-binding domain) in skeletal muscle</h3><p id="__p17" class="p p-first">As discussed, ROR&#x003b1; has been demonstrated to regulate fat metabolism in several tissues. We were interested in identifying and validating the (physiologically relevant) <em>in vivo</em> functional role(s) and pathway(s) regulated by ROR&#x003b1; action in skeletal muscle. This major mass peripheral tissue accounts for &#x0223c;40% of the total body mass, significant levels of fatty acid oxidation, glucose disposal and energy demand. We utilized the approach of attenuating ROR&#x003b1; signaling, by the targeted skeletal muscle-specific expression of a truncated ROR&#x003b1;&#x00394;DE (lacking the ligand-binding domain) in transgenic mice, to examine ROR&#x003b1; action in this tissue. This approach was utilized in the absence of the availability of a reproducible and robust, native or synthetic agonist for the modulation of this orphan nuclear receptor.</p><p id="__p18">We produced transgenic mice (by pronuclear injection) that selectively express a transgene encoding truncated human ROR&#x003b1;1 in skeletal muscle [under the control of the human skeletal alpha actin promoter (<a href="#B10" rid="B10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115700">10</a>,<a href="#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115715">11</a>)]. The transgene (ROR&#x003b1;1&#x00394;DE) lacks the ligand-binding domain and part of the hinge region, and encoded amino acids 1&#x02013;235 (<a href="#B6" rid="B6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115691">6</a>). McBroom <em>et al.</em> (<a href="#B21" rid="B21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115731">21</a>) reported that deletion of this segment preserved DNA recognition and binding, suppressed trans-activation and operated in a dominant negative manner. In addition, Hamilton et al<em>.</em> (<a href="#B22" rid="B22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115702">22</a>) reported the staggerer mutation is located in a similar position, and produces a non-functional ligand-binding domain. Moreover, we previously demonstrated in an <em>in vitro</em> myogenic cell culture model that this construct attenuated ROR&#x003b1; mediated <em>trans</em>-activation, and ectopic expression suppressed endogenous ROR&#x003b1; mRNA expression (<a href="#B3" rid="B3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115695">3</a>).</p><p id="__p19" class="p p-last">We observed that the heterozygous transgenic mice predominantly (and abundantly) expressed the ectopic transcript (transgene) in skeletal muscle relative to other organ/tissues (cerebellum, spleen, heart, white adipose, liver and pancreas; <a href="/pmc/articles/PMC2910057/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>A and B). Heart and brain expressed &#x0003c;2% of the ectopic transcript, relative to expression in skeletal muscle. This was consistent with several other studies that utilized this promoter in transgenic models (<a href="#B10" rid="B10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115666">10</a>,<a href="#B12" rid="B12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115664">12</a>,<a href="#B23" rid="B23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115724">23</a>). Quantitative real-time PCR (q-PCR) analysis of mRNA expression demonstrated that the ectopic truncated ROR&#x003b1; transcript was expressed between 3- and 4-fold higher than the endogenous ROR&#x003b1; transcript in the muscle of transgenic mice (<a href="/pmc/articles/PMC2910057/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>A). As expected, the ectopic ROR&#x003b1; transcript was not detectable in wt littermates (data not shown). Concordantly, expression analysis demonstrated that total (endogenous plus ectopic) ROR&#x003b1; transcript expression increased &#x0223c;3-fold in the muscle of transgenic, relative to wt littermate mice (<a href="/pmc/articles/PMC2910057/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>C). In this background we observed a decrease (that did not attain significance) in the levels of total endogenous ROR&#x003b1;1 and 4 mRNA expression in the muscle of transgenic relative to wt littermate mice (<a href="/pmc/articles/PMC2910057/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>D). Surprisingly, isoform-specific q-PCR analysis of ROR&#x003b1;1 and ROR&#x003b1;4, revealed significant suppression of ROR&#x003b1;1 (but not &#x003b1;4) mRNA expression (<a href="/pmc/articles/PMC2910057/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>E and F). Staels (<a href="#B1" rid="B1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115739">1</a>,<a href="#B5" rid="B5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115680">5</a>) and our group (<a href="#B3" rid="B3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115661">3</a>,<a href="#B8" rid="B8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115725">8</a>) amongst others have previously demonstrated that the &#x003b1;1 isoform has a physiological role in the regulation of lipid homeostasis. To further characterize the line of mice, we examined expression of a bona fide ROR&#x003b1; (1 and 4) target gene, apolipoprotein A5, characterized by two independent groups (<a href="#B24" rid="B24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115698">24</a>,<a href="#B25" rid="B25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115705">25</a>), which was very significantly decreased in the Tg-ROR&#x003b1;1&#x00394;DE mice (<a href="/pmc/articles/PMC2910057/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>G). These data demonstrate the line of Tg-ROR&#x003b1;1&#x00394;DE mice, express the ectopic transcript, suppress endogenous ROR&#x003b1;1 mRNA expression and attenuate ROR&#x003b1;1-dependent gene expression.
</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC2910057/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140662068558240" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2910057_gkq180f1.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is gkq180f1.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2910057/bin/gkq180f1.jpg" /></a></div><div id="largeobj_idm140662068558240" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2910057/figure/F1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC2910057/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1.</a></div><!--caption a7--><div class="caption"><p id="__p20">(<strong>A</strong>) qPCR of the ectopic transgene gene (hROR&#x003b1;1&#x00394;DE) and endogenous ROR&#x003b1; expression in various tissue/organs in heterozygous transgenic mice. Relative mRNA expression is normalized against 18S mRNA (<em>n</em> = 6/group, mean &#x000b1; SEM, ***<em>P</em> &#x0003c; 0.001). (<strong>B</strong>) qPCR of the ectopic transgene gene (hROR&#x003b1;1&#x00394;DE) in pancreas versus skeletal muscle from wild-type and heterozygous transgenic mice. Relative mRNA expression is normalized against 18S mRNA (<em>n</em> = 6/group). (<strong>C</strong>) qPCR of total ROR&#x003b1; (ectopic and endogenous) in skeletal muscle of wild-type and transgenic mice. Relative fold change of (mRNA expression) is normalized against 18S mRNA (<em>n</em> = 6/group, mean &#x000b1; SEM, ***<em>P</em> &#x0003c; 0.001). qPCR of (<strong>D</strong>) endogenous ROR&#x003b1;1 and 4; (<strong>E</strong>) endogenous ROR&#x003b1;1and<strong>F</strong>)endogenous ROR&#x003b1;4 mRNA expression in skeletal muscle of wild-type and transgenic mice. Relative fold change of (mRNA expression) is normalized against 18S mRNA (<em>n</em> = 6/group, mean &#x000b1; SEM), *<em>P</em> &#x0003c; 0.05. (<strong>G</strong>) qPCR of ApoA5 mRNA expression in skeletal muscle of wild-type and transgenic mice. Relative fold change of (mRNA expression) is normalized against 18S mRNA (<em>n</em> = 6/group, mean &#x000b1; SEM, ***<em>P</em> &#x0003c; 0.001).</p></div></div></div></div><div id="__sec15" class="sec"><h3>Expression profiling of skeletal muscle from the ROR&#x003b1;1&#x00394;DE mice: identification of functions and pathways</h3><p id="__p21" class="p p-first">To rigorously identify the <em>in vivo</em> functional role(s), and pathway(s) regulated by ROR&#x003b1; action in skeletal muscle, we carried out expression profiling coupled to functional and signaling characterization by Ingenuity pathway analysis (<a href="http://nar.oxfordjournals.org/cgi/content/full/gkq180/DC1" ref="reftype=extlink&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">Supplementary Figures S2&#x02013;S5</a>). Using a <em>P</em> value cut-off of <em>P</em> &#x0003c; 0.05 and a fold change cut off of 1.3, the top 50 annotated genes that were differentially up- and down-regulated in a significant manner are shown in <a href="/pmc/articles/PMC2910057/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Tables 1</span></a> and <a href="/pmc/articles/PMC2910057/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1.5em;">and2,</span></span><span>2</span></a>, respectively [the complete list of genes (including the non-annotated genes) is shown in <a href="http://nar.oxfordjournals.org/cgi/content/full/gkq180/DC1" ref="reftype=extlink&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">Supplementary Figure S2</a>. In concordance with the overexpression of a dominant negative, the expression profiling, Genespring and Ingenuity analysis identifies a majority of genes in the down regulated category, and the bulk of highly ranked functions and pathways were attenuated/suppressed (This is evident in the complete list of genes in <a href="http://nar.oxfordjournals.org/cgi/content/full/gkq180/DC1" ref="reftype=extlink&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">Supplementary Figure S2</a> and in the graphical representations of the data in <a href="http://nar.oxfordjournals.org/cgi/content/full/gkq180/DC1" ref="reftype=extlink&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">Supplementary Figures S3&#x02013;S5</a>).

</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table 1.</h3><!--caption a7--><div class="caption"><p id="__p22">Downregulated annotated genes in ROR&#x003b1;1&#x00394;DE</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140662074351856" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead align="left"><tr><th rowspan="1" colspan="1">Symbol</th><th rowspan="1" colspan="1">Gene name</th><th rowspan="1" colspan="1">Fold change</th><th rowspan="1" colspan="1"><em>P</em>-value</th><th rowspan="1" colspan="1">Accession number</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">Ucp1</td><td rowspan="1" colspan="1">Uncoupling protein 1</td><td rowspan="1" colspan="1">34.89</td><td rowspan="1" colspan="1">0.000</td><td rowspan="1" colspan="1"><a id="__tag_362115850" class="tag_hotlink" href="/nuccore/NM_009463.2" ref="/nuccore/NM_009463.2"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_009463.2","term_id":"31981931","term_text":"NM_009463.2"}}</span>NM_009463.2</a></td></tr><tr><td rowspan="1" colspan="1">Fasn</td><td rowspan="1" colspan="1">Fatty acid synthase</td><td rowspan="1" colspan="1">8.96</td><td rowspan="1" colspan="1">0.001</td><td rowspan="1" colspan="1"><a id="__tag_362115887" class="tag_hotlink" href="/nuccore/NM_007988.3" ref="/nuccore/NM_007988.3"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_007988.3","term_id":"93102408","term_text":"NM_007988.3"}}</span>NM_007988.3</a></td></tr><tr><td rowspan="1" colspan="1">Cidea</td><td rowspan="1" colspan="1">Cell death-inducing DNA fragmentation factor, alpha subunit-like effector A</td><td rowspan="1" colspan="1">8.58</td><td rowspan="1" colspan="1">0.000</td><td rowspan="1" colspan="1"><a id="__tag_362115918" class="tag_hotlink" href="/nuccore/NM_007702.1" ref="/nuccore/NM_007702.1"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_007702.1","term_id":"6680943","term_text":"NM_007702.1"}}</span>NM_007702.1</a></td></tr><tr><td rowspan="1" colspan="1">Scd1</td><td rowspan="1" colspan="1">Stearoyl-Coenzyme A desaturase 1</td><td rowspan="1" colspan="1">5.47</td><td rowspan="1" colspan="1">0.004</td><td rowspan="1" colspan="1"><a id="__tag_362115881" class="tag_hotlink" href="/nuccore/NM_009127.3" ref="/nuccore/NM_009127.3"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_009127.3","term_id":"118130513","term_text":"NM_009127.3"}}</span>NM_009127.3</a></td></tr><tr><td rowspan="1" colspan="1">Hp</td><td rowspan="1" colspan="1">Haptoglobin</td><td rowspan="1" colspan="1">4.22</td><td rowspan="1" colspan="1">0.004</td><td rowspan="1" colspan="1"><a id="__tag_362115844" class="tag_hotlink" href="/nuccore/NM_017370.1" ref="/nuccore/NM_017370.1"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_017370.1","term_id":"8850218","term_text":"NM_017370.1"}}</span>NM_017370.1</a></td></tr><tr><td rowspan="1" colspan="1">Prkar2b</td><td rowspan="1" colspan="1">Protein kinase, camp dependent regulatory, type II beta</td><td rowspan="1" colspan="1">4.06</td><td rowspan="1" colspan="1">0.004</td><td rowspan="1" colspan="1"><a id="__tag_362115904" class="tag_hotlink" href="/nuccore/NM_011158.3" ref="/nuccore/NM_011158.3"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_011158.3","term_id":"89179324","term_text":"NM_011158.3"}}</span>NM_011158.3</a></td></tr><tr><td rowspan="1" colspan="1">Apoc1</td><td rowspan="1" colspan="1">Apolipoprotein C-I</td><td rowspan="1" colspan="1">3.11</td><td rowspan="1" colspan="1">0.006</td><td rowspan="1" colspan="1"><a id="__tag_362115891" class="tag_hotlink" href="/nuccore/NM_007469.2" ref="/nuccore/NM_007469.2"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_007469.2","term_id":"31982506","term_text":"NM_007469.2"}}</span>NM_007469.2</a></td></tr><tr><td rowspan="1" colspan="1">Igh-6</td><td rowspan="1" colspan="1">Immunoglobulin heavy chain 6 (heavy chain of IgM)</td><td rowspan="1" colspan="1">2.93</td><td rowspan="1" colspan="1">0.014</td><td rowspan="1" colspan="1"><a id="__tag_362115860" class="tag_hotlink" href="/nuccore/XM_354710.1" ref="/nuccore/XM_354710.1"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"XM_354710.1","term_id":"38073786","term_text":"XM_354710.1"}}</span>XM_354710.1</a></td></tr><tr><td rowspan="1" colspan="1">Fah</td><td rowspan="1" colspan="1">Fumarylacetoacetate hydrolase</td><td rowspan="1" colspan="1">2.72</td><td rowspan="1" colspan="1">0.008</td><td rowspan="1" colspan="1"><a id="__tag_362115878" class="tag_hotlink" href="/nuccore/NM_010176.1" ref="/nuccore/NM_010176.1"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_010176.1","term_id":"6753813","term_text":"NM_010176.1"}}</span>NM_010176.1</a></td></tr><tr><td rowspan="1" colspan="1">Tmem45b</td><td rowspan="1" colspan="1">Transmembrane protein 45b</td><td rowspan="1" colspan="1">2.62</td><td rowspan="1" colspan="1">0.000</td><td rowspan="1" colspan="1"><a id="__tag_362115908" class="tag_hotlink" href="/nuccore/NM_144936.1" ref="/nuccore/NM_144936.1"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_144936.1","term_id":"21450348","term_text":"NM_144936.1"}}</span>NM_144936.1</a></td></tr><tr><td rowspan="1" colspan="1">Elovl6</td><td rowspan="1" colspan="1">ELOVL family member 6, elongation of long chain fatty acids</td><td rowspan="1" colspan="1">2.47</td><td rowspan="1" colspan="1">0.000</td><td rowspan="1" colspan="1"><a id="__tag_362115848" class="tag_hotlink" href="/nuccore/NM_130450.2" ref="/nuccore/NM_130450.2"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_130450.2","term_id":"91598889","term_text":"NM_130450.2"}}</span>NM_130450.2</a></td></tr><tr><td rowspan="1" colspan="1">Myo1e</td><td rowspan="1" colspan="1">Myosin IE</td><td rowspan="1" colspan="1">2.43</td><td rowspan="1" colspan="1">0.010</td><td rowspan="1" colspan="1"><a id="__tag_362115929" class="tag_hotlink" href="/nuccore/NM_181072.3" ref="/nuccore/NM_181072.3"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_181072.3","term_id":"68299823","term_text":"NM_181072.3"}}</span>NM_181072.3</a></td></tr><tr><td rowspan="1" colspan="1">Ces3</td><td rowspan="1" colspan="1">Carboxylesterase 3</td><td rowspan="1" colspan="1">2.21</td><td rowspan="1" colspan="1">0.001</td><td rowspan="1" colspan="1"><a id="__tag_362115937" class="tag_hotlink" href="/nuccore/NM_053200.2" ref="/nuccore/NM_053200.2"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_053200.2","term_id":"117553603","term_text":"NM_053200.2"}}</span>NM_053200.2</a></td></tr><tr><td rowspan="1" colspan="1">Sfxn1</td><td rowspan="1" colspan="1">Sideroflexin 1</td><td rowspan="1" colspan="1">2.11</td><td rowspan="1" colspan="1">0.013</td><td rowspan="1" colspan="1"><a id="__tag_362115931" class="tag_hotlink" href="/nuccore/NM_027324.2" ref="/nuccore/NM_027324.2"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_027324.2","term_id":"24476014","term_text":"NM_027324.2"}}</span>NM_027324.2</a></td></tr><tr><td rowspan="1" colspan="1">Acaca</td><td rowspan="1" colspan="1">Acetyl-coenzyme A carboxylase alpha</td><td rowspan="1" colspan="1">2.02</td><td rowspan="1" colspan="1">0.002</td><td rowspan="1" colspan="1"><a id="__tag_362115867" class="tag_hotlink" href="/nuccore/NM_133360.2" ref="/nuccore/NM_133360.2"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_133360.2","term_id":"125656172","term_text":"NM_133360.2"}}</span>NM_133360.2</a></td></tr><tr><td rowspan="1" colspan="1">Rab15</td><td rowspan="1" colspan="1">RAB15, member RAS oncogene family</td><td rowspan="1" colspan="1">2.00</td><td rowspan="1" colspan="1">0.008</td><td rowspan="1" colspan="1"><a id="__tag_362115903" class="tag_hotlink" href="/nuccore/NM_134050.2" ref="/nuccore/NM_134050.2"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_134050.2","term_id":"31559980","term_text":"NM_134050.2"}}</span>NM_134050.2</a></td></tr><tr><td rowspan="1" colspan="1">Cox6a1</td><td rowspan="1" colspan="1">Cytochrome <em>c</em> oxidase, subunit VI a, polypeptide 1</td><td rowspan="1" colspan="1">2.00</td><td rowspan="1" colspan="1">0.000</td><td rowspan="1" colspan="1"><a id="__tag_362115930" class="tag_hotlink" href="/nuccore/NM_007748.3" ref="/nuccore/NM_007748.3"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_007748.3","term_id":"118131168","term_text":"NM_007748.3"}}</span>NM_007748.3</a></td></tr><tr><td rowspan="1" colspan="1">Tkt</td><td rowspan="1" colspan="1">Transketolase</td><td rowspan="1" colspan="1">1.97</td><td rowspan="1" colspan="1">0.004</td><td rowspan="1" colspan="1"><a id="__tag_362115880" class="tag_hotlink" href="/nuccore/NM_009388.2" ref="/nuccore/NM_009388.2"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_009388.2","term_id":"31543868","term_text":"NM_009388.2"}}</span>NM_009388.2</a></td></tr><tr><td rowspan="1" colspan="1">Fgfbp1</td><td rowspan="1" colspan="1">Fibroblast growth factor binding protein 1</td><td rowspan="1" colspan="1">1.90</td><td rowspan="1" colspan="1">0.006</td><td rowspan="1" colspan="1"><a id="__tag_362115938" class="tag_hotlink" href="/nuccore/NM_008009.3" ref="/nuccore/NM_008009.3"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_008009.3","term_id":"47132511","term_text":"NM_008009.3"}}</span>NM_008009.3</a></td></tr><tr><td rowspan="1" colspan="1">Thrsp</td><td rowspan="1" colspan="1">Thyroid hormone responsive SPOT14 homolog</td><td rowspan="1" colspan="1">1.90</td><td rowspan="1" colspan="1">0.006</td><td rowspan="1" colspan="1"><a id="__tag_362115934" class="tag_hotlink" href="/nuccore/NM_009381.2" ref="/nuccore/NM_009381.2"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_009381.2","term_id":"31560631","term_text":"NM_009381.2"}}</span>NM_009381.2</a></td></tr><tr><td rowspan="1" colspan="1">Sfxn1</td><td rowspan="1" colspan="1">Sideroflexin 1</td><td rowspan="1" colspan="1">1.90</td><td rowspan="1" colspan="1">0.010</td><td rowspan="1" colspan="1"><a id="__tag_362115847" class="tag_hotlink" href="/nuccore/NM_027324.2" ref="/nuccore/NM_027324.2"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_027324.2","term_id":"24476014","term_text":"NM_027324.2"}}</span>NM_027324.2</a></td></tr><tr><td rowspan="1" colspan="1">Cox6a1</td><td rowspan="1" colspan="1">Cytochrome <em>c</em> oxidase, subunit VI a, polypeptide 1</td><td rowspan="1" colspan="1">1.86</td><td rowspan="1" colspan="1">0.000</td><td rowspan="1" colspan="1"><a id="__tag_362115914" class="tag_hotlink" href="/nuccore/NM_007748.3" ref="/nuccore/NM_007748.3"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_007748.3","term_id":"118131168","term_text":"NM_007748.3"}}</span>NM_007748.3</a></td></tr><tr><td rowspan="1" colspan="1">D12Ertd647e</td><td rowspan="1" colspan="1">DNA segment, Chr 12, ERATO Doi 647, expressed, transcript variant 4</td><td rowspan="1" colspan="1">1.85</td><td rowspan="1" colspan="1">0.006</td><td rowspan="1" colspan="1"><a id="__tag_362115917" class="tag_hotlink" href="/nuccore/NM_194068.1" ref="/nuccore/NM_194068.1"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_194068.1","term_id":"34732720","term_text":"NM_194068.1"}}</span>NM_194068.1</a></td></tr><tr><td rowspan="1" colspan="1">Agpat2</td><td rowspan="1" colspan="1">1-Acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)</td><td rowspan="1" colspan="1">1.84</td><td rowspan="1" colspan="1">0.000</td><td rowspan="1" colspan="1"><a id="__tag_362115841" class="tag_hotlink" href="/nuccore/NM_026212.1" ref="/nuccore/NM_026212.1"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_026212.1","term_id":"23956161","term_text":"NM_026212.1"}}</span>NM_026212.1</a></td></tr><tr><td rowspan="1" colspan="1">Pygl</td><td rowspan="1" colspan="1">Liver glycogen phosphorylase</td><td rowspan="1" colspan="1">1.84</td><td rowspan="1" colspan="1">0.000</td><td rowspan="1" colspan="1"><a id="__tag_362115885" class="tag_hotlink" href="/nuccore/NM_133198.1" ref="/nuccore/NM_133198.1"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_133198.1","term_id":"18875341","term_text":"NM_133198.1"}}</span>NM_133198.1</a></td></tr><tr><td rowspan="1" colspan="1">Ehhadh</td><td rowspan="1" colspan="1">Enoyl-coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase</td><td rowspan="1" colspan="1">1.83</td><td rowspan="1" colspan="1">0.007</td><td rowspan="1" colspan="1"><a id="__tag_362115920" class="tag_hotlink" href="/nuccore/NM_023737.2" ref="/nuccore/NM_023737.2"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_023737.2","term_id":"31541814","term_text":"NM_023737.2"}}</span>NM_023737.2</a></td></tr><tr><td rowspan="1" colspan="1">Aoc3</td><td rowspan="1" colspan="1">Amine oxidase, copper containing 3</td><td rowspan="1" colspan="1">1.81</td><td rowspan="1" colspan="1">0.012</td><td rowspan="1" colspan="1"><a id="__tag_362115864" class="tag_hotlink" href="/nuccore/NM_009675.1" ref="/nuccore/NM_009675.1"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_009675.1","term_id":"6753065","term_text":"NM_009675.1"}}</span>NM_009675.1</a></td></tr><tr><td rowspan="1" colspan="1">M6prbp1</td><td rowspan="1" colspan="1">Mannose-6-phosphate receptor binding protein 1</td><td rowspan="1" colspan="1">1.81</td><td rowspan="1" colspan="1">0.003</td><td rowspan="1" colspan="1"><a id="__tag_362115893" class="tag_hotlink" href="/nuccore/NM_025836.1" ref="/nuccore/NM_025836.1"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_025836.1","term_id":"13385311","term_text":"NM_025836.1"}}</span>NM_025836.1</a></td></tr><tr><td rowspan="1" colspan="1">Idh1</td><td rowspan="1" colspan="1">Isocitrate dehydrogenase 1 (NADP<sup>+</sup>), soluble</td><td rowspan="1" colspan="1">1.79</td><td rowspan="1" colspan="1">0.007</td><td rowspan="1" colspan="1"><a id="__tag_362115912" class="tag_hotlink" href="/nuccore/NM_010497.2" ref="/nuccore/NM_010497.2"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_010497.2","term_id":"58037545","term_text":"NM_010497.2"}}</span>NM_010497.2</a></td></tr><tr><td rowspan="1" colspan="1">Atp1b4</td><td rowspan="1" colspan="1">Atpase, (Na<sup>+</sup>)/K<sup>+</sup> transporting, beta 4 polypeptide</td><td rowspan="1" colspan="1">1.78</td><td rowspan="1" colspan="1">0.000</td><td rowspan="1" colspan="1"><a id="__tag_362115859" class="tag_hotlink" href="/nuccore/NM_133690.2" ref="/nuccore/NM_133690.2"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_133690.2","term_id":"118130945","term_text":"NM_133690.2"}}</span>NM_133690.2</a></td></tr><tr><td rowspan="1" colspan="1">Exod1</td><td rowspan="1" colspan="1">Exonuclease domain containing 1</td><td rowspan="1" colspan="1">1.77</td><td rowspan="1" colspan="1">0.012</td><td rowspan="1" colspan="1"><a id="__tag_362115913" class="tag_hotlink" href="/nuccore/NM_027698.3" ref="/nuccore/NM_027698.3"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_027698.3","term_id":"61098179","term_text":"NM_027698.3"}}</span>NM_027698.3</a></td></tr><tr><td rowspan="1" colspan="1">Hsd17b12</td><td rowspan="1" colspan="1">Hydroxysteroid (17-beta) dehydrogenase 12</td><td rowspan="1" colspan="1">1.76</td><td rowspan="1" colspan="1">0.002</td><td rowspan="1" colspan="1"><a id="__tag_362115874" class="tag_hotlink" href="/nuccore/NM_019657.2" ref="/nuccore/NM_019657.2"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_019657.2","term_id":"31560410","term_text":"NM_019657.2"}}</span>NM_019657.2</a></td></tr><tr><td rowspan="1" colspan="1">Wnt4</td><td rowspan="1" colspan="1">Wingless-related MMTV integration site 4</td><td rowspan="1" colspan="1">1.76</td><td rowspan="1" colspan="1">0.004</td><td rowspan="1" colspan="1"><a id="__tag_362115901" class="tag_hotlink" href="/nuccore/NM_009523.1" ref="/nuccore/NM_009523.1"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_009523.1","term_id":"6678594","term_text":"NM_009523.1"}}</span>NM_009523.1</a></td></tr><tr><td rowspan="1" colspan="1">Cebpa</td><td rowspan="1" colspan="1">CCAAT/enhancer binding protein</td><td rowspan="1" colspan="1">1.75</td><td rowspan="1" colspan="1">0.005</td><td rowspan="1" colspan="1"><a id="__tag_362115915" class="tag_hotlink" href="/nuccore/NM_007678.2" ref="/nuccore/NM_007678.2"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_007678.2","term_id":"86198300","term_text":"NM_007678.2"}}</span>NM_007678.2</a></td></tr><tr><td rowspan="1" colspan="1">Slc27a2</td><td rowspan="1" colspan="1">Solute carrier family 27 (fatty acid transporter), member 2</td><td rowspan="1" colspan="1">1.73</td><td rowspan="1" colspan="1">0.009</td><td rowspan="1" colspan="1"><a id="__tag_362115856" class="tag_hotlink" href="/nuccore/NM_011978.2" ref="/nuccore/NM_011978.2"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_011978.2","term_id":"113374153","term_text":"NM_011978.2"}}</span>NM_011978.2</a></td></tr><tr><td rowspan="1" colspan="1">Apoc1</td><td rowspan="1" colspan="1">Apolipoprotein C-I</td><td rowspan="1" colspan="1">1.72</td><td rowspan="1" colspan="1">0.013</td><td rowspan="1" colspan="1"><a id="__tag_362115940" class="tag_hotlink" href="/nuccore/NM_007469.2" ref="/nuccore/NM_007469.2"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_007469.2","term_id":"31982506","term_text":"NM_007469.2"}}</span>NM_007469.2</a></td></tr><tr><td rowspan="1" colspan="1">Tmcc3</td><td rowspan="1" colspan="1">Transmembrane and coiled coil domains 3</td><td rowspan="1" colspan="1">1.71</td><td rowspan="1" colspan="1">0.004</td><td rowspan="1" colspan="1"><a id="__tag_362115862" class="tag_hotlink" href="/nuccore/NM_172051.2" ref="/nuccore/NM_172051.2"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_172051.2","term_id":"78771619","term_text":"NM_172051.2"}}</span>NM_172051.2</a></td></tr><tr><td rowspan="1" colspan="1">Zfp691</td><td rowspan="1" colspan="1">Zinc finger protein 691</td><td rowspan="1" colspan="1">1.71</td><td rowspan="1" colspan="1">0.000</td><td rowspan="1" colspan="1"><a id="__tag_362115896" class="tag_hotlink" href="/nuccore/NM_183140.1" ref="/nuccore/NM_183140.1"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_183140.1","term_id":"34147152","term_text":"NM_183140.1"}}</span>NM_183140.1</a></td></tr><tr><td rowspan="1" colspan="1">Olfm1</td><td rowspan="1" colspan="1">Olfactomedin 1, transcript variant 2</td><td rowspan="1" colspan="1">1.68</td><td rowspan="1" colspan="1">0.010</td><td rowspan="1" colspan="1"><a id="__tag_362115884" class="tag_hotlink" href="/nuccore/NM_001038612.1" ref="/nuccore/NM_001038612.1"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_001038612.1","term_id":"84370348","term_text":"NM_001038612.1"}}</span>NM_001038612.1</a></td></tr><tr><td rowspan="1" colspan="1">Gnao1</td><td rowspan="1" colspan="1">Guanine nucleotide binding protein, alpha o</td><td rowspan="1" colspan="1">1.68</td><td rowspan="1" colspan="1">0.007</td><td rowspan="1" colspan="1"><a id="__tag_362115842" class="tag_hotlink" href="/nuccore/NM_010308.3" ref="/nuccore/NM_010308.3"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_010308.3","term_id":"116325994","term_text":"NM_010308.3"}}</span>NM_010308.3</a></td></tr><tr><td rowspan="1" colspan="1">Gcat</td><td rowspan="1" colspan="1">Glycine C-acetyltransferase (2-amino-3-ketobutyrate coenzyme A ligase)</td><td rowspan="1" colspan="1">1.67</td><td rowspan="1" colspan="1">0.012</td><td rowspan="1" colspan="1"><a id="__tag_362115936" class="tag_hotlink" href="/nuccore/NM_013847" ref="/nuccore/NM_013847"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_013847","term_id":"240120116","term_text":"NM_013847"}}</span>NM_013847</a></td></tr><tr><td rowspan="1" colspan="1">Abhd8</td><td rowspan="1" colspan="1">Abhydrolase domain containing 8</td><td rowspan="1" colspan="1">1.64</td><td rowspan="1" colspan="1">0.005</td><td rowspan="1" colspan="1"><a id="__tag_362115888" class="tag_hotlink" href="/nuccore/NM_022419.1" ref="/nuccore/NM_022419.1"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_022419.1","term_id":"11967946","term_text":"NM_022419.1"}}</span>NM_022419.1</a></td></tr><tr><td rowspan="1" colspan="1">Pparg</td><td rowspan="1" colspan="1">Peroxisome proliferator activated receptor gamma</td><td rowspan="1" colspan="1">1.64</td><td rowspan="1" colspan="1">0.001</td><td rowspan="1" colspan="1"><a id="__tag_362115868" class="tag_hotlink" href="/nuccore/NM_011146.1" ref="/nuccore/NM_011146.1"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_011146.1","term_id":"6755137","term_text":"NM_011146.1"}}</span>NM_011146.1</a></td></tr><tr><td rowspan="1" colspan="1">Cox8a</td><td rowspan="1" colspan="1">Cytochrome <em>c</em> oxidase, subunit viiia</td><td rowspan="1" colspan="1">1.63</td><td rowspan="1" colspan="1">0.001</td><td rowspan="1" colspan="1"><a id="__tag_362115895" class="tag_hotlink" href="/nuccore/NM_007750.2" ref="/nuccore/NM_007750.2"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_007750.2","term_id":"84000428","term_text":"NM_007750.2"}}</span>NM_007750.2</a></td></tr><tr><td rowspan="1" colspan="1">Tspo</td><td rowspan="1" colspan="1">Translocator protein</td><td rowspan="1" colspan="1">1.62</td><td rowspan="1" colspan="1">0.001</td><td rowspan="1" colspan="1"><a id="__tag_362115889" class="tag_hotlink" href="/nuccore/NM_009775.2" ref="/nuccore/NM_009775.2"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_009775.2","term_id":"31981874","term_text":"NM_009775.2"}}</span>NM_009775.2</a></td></tr><tr><td rowspan="1" colspan="1">Lrtm1</td><td rowspan="1" colspan="1">Leucine-rich repeats and transmembrane domains 1</td><td rowspan="1" colspan="1">1.62</td><td rowspan="1" colspan="1">0.001</td><td rowspan="1" colspan="1"><a id="__tag_362115879" class="tag_hotlink" href="/nuccore/NM_176920.2" ref="/nuccore/NM_176920.2"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_176920.2","term_id":"31342391","term_text":"NM_176920.2"}}</span>NM_176920.2</a></td></tr><tr><td rowspan="1" colspan="1">Igh-1a</td><td rowspan="1" colspan="1">Immunoglobulin heavy chain 1a</td><td rowspan="1" colspan="1">1.62</td><td rowspan="1" colspan="1">0.002</td><td rowspan="1" colspan="1"><a id="__tag_362115928" class="tag_hotlink" href="/nuccore/XM_354704.1" ref="/nuccore/XM_354704.1"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"XM_354704.1","term_id":"38073776","term_text":"XM_354704.1"}}</span>XM_354704.1</a></td></tr><tr><td rowspan="1" colspan="1">Slc16a10</td><td rowspan="1" colspan="1">Solute carrier family 16 (monocarboxylic acid transporters), member 10</td><td rowspan="1" colspan="1">1.62</td><td rowspan="1" colspan="1">0.001</td><td rowspan="1" colspan="1"><a id="__tag_362115873" class="tag_hotlink" href="/nuccore/NM_028247.1" ref="/nuccore/NM_028247.1"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_028247.1","term_id":"30794381","term_text":"NM_028247.1"}}</span>NM_028247.1</a></td></tr><tr><td rowspan="1" colspan="1">Tspo</td><td rowspan="1" colspan="1">Translocator protein</td><td rowspan="1" colspan="1">1.60</td><td rowspan="1" colspan="1">0.003</td><td rowspan="1" colspan="1"><a id="__tag_362115858" class="tag_hotlink" href="/nuccore/NM_009775.2" ref="/nuccore/NM_009775.2"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_009775.2","term_id":"31981874","term_text":"NM_009775.2"}}</span>NM_009775.2</a></td></tr><tr><td rowspan="1" colspan="1">Hsd11b1</td><td rowspan="1" colspan="1">Hydroxysteroid 11-beta dehydrogenase 1, transcript variant 2</td><td rowspan="1" colspan="1">1.60</td><td rowspan="1" colspan="1">0.001</td><td rowspan="1" colspan="1"><a id="__tag_362115933" class="tag_hotlink" href="/nuccore/NM_001044751.1" ref="/nuccore/NM_001044751.1"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_001044751.1","term_id":"113680660","term_text":"NM_001044751.1"}}</span>NM_001044751.1</a></td></tr></tbody></table></div><div id="largeobj_idm140662074351856" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2910057/table/T1/?report=objectonly">Open in a separate window</a></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T2"><h3>Table 2.</h3><!--caption a7--><div class="caption"><p id="__p23">Upregulated annotated genes in ROR&#x003b1;1&#x00394;DE</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140662071382960" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead align="left"><tr><th rowspan="1" colspan="1">Symbol</th><th rowspan="1" colspan="1">Gene name</th><th rowspan="1" colspan="1">Fold change</th><th rowspan="1" colspan="1"><em>P</em>-value</th><th rowspan="1" colspan="1">Accession number</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">Zranb3</td><td rowspan="1" colspan="1">Zinc finger, RAN-binding domain containing 3</td><td rowspan="1" colspan="1">2.64</td><td rowspan="1" colspan="1">0.000</td><td rowspan="1" colspan="1"><a id="__tag_362115906" class="tag_hotlink" href="/nuccore/NM_172642.1" ref="/nuccore/NM_172642.1"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_172642.1","term_id":"124430712","term_text":"NM_172642.1"}}</span>NM_172642.1</a></td></tr><tr><td rowspan="1" colspan="1">Rom1</td><td rowspan="1" colspan="1">Rod outer segment membrane protein 1</td><td rowspan="1" colspan="1">2.54</td><td rowspan="1" colspan="1">0.000</td><td rowspan="1" colspan="1"><a id="__tag_362115852" class="tag_hotlink" href="/nuccore/NM_009073.2" ref="/nuccore/NM_009073.2"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_009073.2","term_id":"83699399","term_text":"NM_009073.2"}}</span>NM_009073.2</a></td></tr><tr><td rowspan="1" colspan="1">Tceal5</td><td rowspan="1" colspan="1">Transcription elongation factor A (SII)-like 5</td><td rowspan="1" colspan="1">2.43</td><td rowspan="1" colspan="1">0.001</td><td rowspan="1" colspan="1"><a id="__tag_362115900" class="tag_hotlink" href="/nuccore/NM_177919.1" ref="/nuccore/NM_177919.1"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_177919.1","term_id":"46559433","term_text":"NM_177919.1"}}</span>NM_177919.1</a></td></tr><tr><td rowspan="1" colspan="1">Col7a1</td><td rowspan="1" colspan="1">Procollagen, type VII, alpha 1</td><td rowspan="1" colspan="1">2.21</td><td rowspan="1" colspan="1">0.010</td><td rowspan="1" colspan="1"><a id="__tag_362115898" class="tag_hotlink" href="/nuccore/NM_007738.3" ref="/nuccore/NM_007738.3"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_007738.3","term_id":"115647998","term_text":"NM_007738.3"}}</span>NM_007738.3</a></td></tr><tr><td rowspan="1" colspan="1">Plekhb1</td><td rowspan="1" colspan="1">Pleckstrin homology domain containing, family B (evectins) member 1</td><td rowspan="1" colspan="1">2.10</td><td rowspan="1" colspan="1">0.001</td><td rowspan="1" colspan="1"><a id="__tag_362115855" class="tag_hotlink" href="/nuccore/NM_013746.1" ref="/nuccore/NM_013746.1"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_013746.1","term_id":"7305378","term_text":"NM_013746.1"}}</span>NM_013746.1</a></td></tr><tr><td rowspan="1" colspan="1">Tnfrsf22</td><td rowspan="1" colspan="1">Tumor necrosis factor receptor superfamily, member 22</td><td rowspan="1" colspan="1">2.10</td><td rowspan="1" colspan="1">0.001</td><td rowspan="1" colspan="1"><a id="__tag_362115925" class="tag_hotlink" href="/nuccore/NM_023680.2" ref="/nuccore/NM_023680.2"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_023680.2","term_id":"34328313","term_text":"NM_023680.2"}}</span>NM_023680.2</a></td></tr><tr><td rowspan="1" colspan="1">Tnfrsf22</td><td rowspan="1" colspan="1">Tumor necrosis factor receptor superfamily, member 22</td><td rowspan="1" colspan="1">1.94</td><td rowspan="1" colspan="1">0.001</td><td rowspan="1" colspan="1"><a id="__tag_508212035" class="tag_hotlink" href="/nuccore/NM_023680" ref="/nuccore/NM_023680"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_023680","term_id":"902763380","term_text":"NM_023680"}}</span>NM_023680</a></td></tr><tr><td rowspan="1" colspan="1">Gfer</td><td rowspan="1" colspan="1">Growth factor, erv1 (<em>S. cerevisiae</em>)-like (augmenter of liver regeneration)</td><td rowspan="1" colspan="1">1.90</td><td rowspan="1" colspan="1">0.000</td><td rowspan="1" colspan="1"><a id="__tag_362115865" class="tag_hotlink" href="/nuccore/NM_023040.3" ref="/nuccore/NM_023040.3"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_023040.3","term_id":"90403593","term_text":"NM_023040.3"}}</span>NM_023040.3</a></td></tr><tr><td rowspan="1" colspan="1">Tob1</td><td rowspan="1" colspan="1">Transducer of erbb-2.1</td><td rowspan="1" colspan="1">1.79</td><td rowspan="1" colspan="1">0.011</td><td rowspan="1" colspan="1"><a id="__tag_362115919" class="tag_hotlink" href="/nuccore/NM_009427.2" ref="/nuccore/NM_009427.2"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_009427.2","term_id":"61676218","term_text":"NM_009427.2"}}</span>NM_009427.2</a></td></tr><tr><td rowspan="1" colspan="1">Stab2</td><td rowspan="1" colspan="1">Stabilin 2</td><td rowspan="1" colspan="1">1.79</td><td rowspan="1" colspan="1">0.001</td><td rowspan="1" colspan="1"><a id="__tag_362115843" class="tag_hotlink" href="/nuccore/NM_138673.1" ref="/nuccore/NM_138673.1"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_138673.1","term_id":"20149763","term_text":"NM_138673.1"}}</span>NM_138673.1</a></td></tr><tr><td rowspan="1" colspan="1">Camk2n2</td><td rowspan="1" colspan="1">PREDICTED: calcium/calmodulin-dependent protein kinase II inhibitor 2</td><td rowspan="1" colspan="1">1.77</td><td rowspan="1" colspan="1">0.003</td><td rowspan="1" colspan="1"><a id="__tag_362115849" class="tag_hotlink" href="/nuccore/XM_993468.1" ref="/nuccore/XM_993468.1"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"XM_993468.1","term_id":"94401056","term_text":"XM_993468.1"}}</span>XM_993468.1</a></td></tr><tr><td rowspan="1" colspan="1">Il17re</td><td rowspan="1" colspan="1">Interleukin 17 receptor E, transcript variant 2</td><td rowspan="1" colspan="1">1.71</td><td rowspan="1" colspan="1">0.001</td><td rowspan="1" colspan="1"><a id="__tag_362115869" class="tag_hotlink" href="/nuccore/NM_001034029.1" ref="/nuccore/NM_001034029.1"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_001034029.1","term_id":"77404280","term_text":"NM_001034029.1"}}</span>NM_001034029.1</a></td></tr><tr><td rowspan="1" colspan="1">Lgals1</td><td rowspan="1" colspan="1">Lectin, galactose binding, soluble 1</td><td rowspan="1" colspan="1">1.61</td><td rowspan="1" colspan="1">0.000</td><td rowspan="1" colspan="1"><a id="__tag_362115846" class="tag_hotlink" href="/nuccore/NM_008495.2" ref="/nuccore/NM_008495.2"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_008495.2","term_id":"85838506","term_text":"NM_008495.2"}}</span>NM_008495.2</a></td></tr><tr><td rowspan="1" colspan="1">Slc22a4</td><td rowspan="1" colspan="1">Solute carrier family 22 (organic cation transporter), member 4</td><td rowspan="1" colspan="1">1.61</td><td rowspan="1" colspan="1">0.007</td><td rowspan="1" colspan="1"><a id="__tag_362115890" class="tag_hotlink" href="/nuccore/NM_019687.3" ref="/nuccore/NM_019687.3"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_019687.3","term_id":"118130537","term_text":"NM_019687.3"}}</span>NM_019687.3</a></td></tr><tr><td rowspan="1" colspan="1">Ush1c</td><td rowspan="1" colspan="1">Usher syndrome 1C homolog, transcript variant a1</td><td rowspan="1" colspan="1">1.59</td><td rowspan="1" colspan="1">0.008</td><td rowspan="1" colspan="1"><a id="__tag_362115923" class="tag_hotlink" href="/nuccore/NM_023649.1" ref="/nuccore/NM_023649.1"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_023649.1","term_id":"12963768","term_text":"NM_023649.1"}}</span>NM_023649.1</a></td></tr><tr><td rowspan="1" colspan="1">Maged2</td><td rowspan="1" colspan="1">Melanoma antigen, family D, 2</td><td rowspan="1" colspan="1">1.55</td><td rowspan="1" colspan="1">0.003</td><td rowspan="1" colspan="1"><a id="__tag_362115916" class="tag_hotlink" href="/nuccore/NM_030700.1" ref="/nuccore/NM_030700.1"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_030700.1","term_id":"13507637","term_text":"NM_030700.1"}}</span>NM_030700.1</a></td></tr><tr><td rowspan="1" colspan="1">Gdf11</td><td rowspan="1" colspan="1">Growth differentiation factor 11</td><td rowspan="1" colspan="1">1.52</td><td rowspan="1" colspan="1">0.007</td><td rowspan="1" colspan="1"><a id="__tag_362115907" class="tag_hotlink" href="/nuccore/NM_010272.1" ref="/nuccore/NM_010272.1"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_010272.1","term_id":"112807179","term_text":"NM_010272.1"}}</span>NM_010272.1</a></td></tr><tr><td rowspan="1" colspan="1">Sfxn3</td><td rowspan="1" colspan="1">Sideroflexin 3</td><td rowspan="1" colspan="1">1.50</td><td rowspan="1" colspan="1">0.010</td><td rowspan="1" colspan="1"><a id="__tag_362115927" class="tag_hotlink" href="/nuccore/NM_053197.2" ref="/nuccore/NM_053197.2"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_053197.2","term_id":"31981487","term_text":"NM_053197.2"}}</span>NM_053197.2</a></td></tr><tr><td rowspan="1" colspan="1">Rab11fip5</td><td rowspan="1" colspan="1">RAB11 family interacting protein 5 (class I), transcript variant 2</td><td rowspan="1" colspan="1">1.50</td><td rowspan="1" colspan="1">0.009</td><td rowspan="1" colspan="1"><a id="__tag_362115922" class="tag_hotlink" href="/nuccore/NM_177466.4" ref="/nuccore/NM_177466.4"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_177466.4","term_id":"55743142","term_text":"NM_177466.4"}}</span>NM_177466.4</a></td></tr><tr><td rowspan="1" colspan="1">Synpo2l</td><td rowspan="1" colspan="1">Synaptopodin 2-like</td><td rowspan="1" colspan="1">1.50</td><td rowspan="1" colspan="1">0.008</td><td rowspan="1" colspan="1"><a id="__tag_362115876" class="tag_hotlink" href="/nuccore/NM_175132.3" ref="/nuccore/NM_175132.3"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_175132.3","term_id":"118129847","term_text":"NM_175132.3"}}</span>NM_175132.3</a></td></tr><tr><td rowspan="1" colspan="1">Hes1</td><td rowspan="1" colspan="1">Hairy and enhancer of split 1</td><td rowspan="1" colspan="1">1.49</td><td rowspan="1" colspan="1">0.001</td><td rowspan="1" colspan="1"><a id="__tag_362115883" class="tag_hotlink" href="/nuccore/NM_008235.2" ref="/nuccore/NM_008235.2"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_008235.2","term_id":"31560817","term_text":"NM_008235.2"}}</span>NM_008235.2</a></td></tr><tr><td rowspan="1" colspan="1">Actr1b</td><td rowspan="1" colspan="1">ARP1 actin-related protein 1 homolog B, centractin beta (yeast)</td><td rowspan="1" colspan="1">1.47</td><td rowspan="1" colspan="1">0.001</td><td rowspan="1" colspan="1"><a id="__tag_362115939" class="tag_hotlink" href="/nuccore/NM_146107" ref="/nuccore/NM_146107"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_146107","term_id":"118130225","term_text":"NM_146107"}}</span>NM_146107</a></td></tr><tr><td rowspan="1" colspan="1">Actr1b</td><td rowspan="1" colspan="1">ARP1 actin-related protein 1 homolog B</td><td rowspan="1" colspan="1">1.47</td><td rowspan="1" colspan="1">0.007</td><td rowspan="1" colspan="1"><a id="__tag_362115932" class="tag_hotlink" href="/nuccore/NM_146107.2" ref="/nuccore/NM_146107.2"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_146107.2","term_id":"118130225","term_text":"NM_146107.2"}}</span>NM_146107.2</a></td></tr><tr><td rowspan="1" colspan="1">Rala</td><td rowspan="1" colspan="1">V-ral simian leukemia viral oncogene homolog A (ras related)</td><td rowspan="1" colspan="1">1.47</td><td rowspan="1" colspan="1">0.004</td><td rowspan="1" colspan="1"><a id="__tag_362115863" class="tag_hotlink" href="/nuccore/NM_019491.5" ref="/nuccore/NM_019491.5"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_019491.5","term_id":"118130690","term_text":"NM_019491.5"}}</span>NM_019491.5</a></td></tr><tr><td rowspan="1" colspan="1">Sms</td><td rowspan="1" colspan="1">Spermine synthase</td><td rowspan="1" colspan="1">1.46</td><td rowspan="1" colspan="1">0.000</td><td rowspan="1" colspan="1"><a id="__tag_362115935" class="tag_hotlink" href="/nuccore/NM_009214.3" ref="/nuccore/NM_009214.3"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_009214.3","term_id":"118600997","term_text":"NM_009214.3"}}</span>NM_009214.3</a></td></tr><tr><td rowspan="1" colspan="1">C1qtnf4</td><td rowspan="1" colspan="1">C1q and tumor necrosis factor related protein 4</td><td rowspan="1" colspan="1">1.44</td><td rowspan="1" colspan="1">0.006</td><td rowspan="1" colspan="1"><a id="__tag_362115854" class="tag_hotlink" href="/nuccore/NM_026161.1" ref="/nuccore/NM_026161.1"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_026161.1","term_id":"13385665","term_text":"NM_026161.1"}}</span>NM_026161.1</a></td></tr><tr><td rowspan="1" colspan="1">Sorl1</td><td rowspan="1" colspan="1">Sortilin-related receptor containing LDLR class A repeats</td><td rowspan="1" colspan="1">1.42</td><td rowspan="1" colspan="1">0.009</td><td rowspan="1" colspan="1"><a id="__tag_694190302" class="tag_hotlink" href="/nuccore/NM_011436" ref="/nuccore/NM_011436"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_011436","term_id":"1269208348","term_text":"NM_011436"}}</span>NM_011436</a></td></tr><tr><td rowspan="1" colspan="1">Des</td><td rowspan="1" colspan="1">Desmin</td><td rowspan="1" colspan="1">1.42</td><td rowspan="1" colspan="1">0.004</td><td rowspan="1" colspan="1"><a id="__tag_362115875" class="tag_hotlink" href="/nuccore/NM_010043.1" ref="/nuccore/NM_010043.1"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_010043.1","term_id":"33563249","term_text":"NM_010043.1"}}</span>NM_010043.1</a></td></tr><tr><td rowspan="1" colspan="1">Nans</td><td rowspan="1" colspan="1">N-acetylneuraminic acid synthase (sialic acid synthase)</td><td rowspan="1" colspan="1">1.40</td><td rowspan="1" colspan="1">0.002</td><td rowspan="1" colspan="1"><a id="__tag_362115910" class="tag_hotlink" href="/nuccore/NM_053179.2" ref="/nuccore/NM_053179.2"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_053179.2","term_id":"31560007","term_text":"NM_053179.2"}}</span>NM_053179.2</a></td></tr><tr><td rowspan="1" colspan="1">Ccl25</td><td rowspan="1" colspan="1">Chemokine (C-C motif) ligand 25</td><td rowspan="1" colspan="1">1.40</td><td rowspan="1" colspan="1">0.002</td><td rowspan="1" colspan="1"><a id="__tag_362115886" class="tag_hotlink" href="/nuccore/NM_009138.1" ref="/nuccore/NM_009138.1"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_009138.1","term_id":"6677880","term_text":"NM_009138.1"}}</span>NM_009138.1</a></td></tr><tr><td rowspan="1" colspan="1">Rrm1</td><td rowspan="1" colspan="1">Ribonucleotide reductase M1</td><td rowspan="1" colspan="1">1.39</td><td rowspan="1" colspan="1">0.002</td><td rowspan="1" colspan="1"><a id="__tag_362115921" class="tag_hotlink" href="/nuccore/NM_009103" ref="/nuccore/NM_009103"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_009103","term_id":"254750731","term_text":"NM_009103"}}</span>NM_009103</a></td></tr><tr><td rowspan="1" colspan="1">Eif1ay</td><td rowspan="1" colspan="1">Eukaryotic translation initiation factor 1A, Y-linked</td><td rowspan="1" colspan="1">1.39</td><td rowspan="1" colspan="1">0.012</td><td rowspan="1" colspan="1"><a id="__tag_694190303" class="tag_hotlink" href="/nuccore/NM_025437" ref="/nuccore/NM_025437"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_025437","term_id":"1327848629","term_text":"NM_025437"}}</span>NM_025437</a></td></tr><tr><td rowspan="1" colspan="1">Setd8</td><td rowspan="1" colspan="1">SET domain containing (lysine methyltransferase) 8</td><td rowspan="1" colspan="1">1.38</td><td rowspan="1" colspan="1">0.007</td><td rowspan="1" colspan="1"><a id="__tag_362115894" class="tag_hotlink" href="/nuccore/NM_030241.2" ref="/nuccore/NM_030241.2"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_030241.2","term_id":"45580701","term_text":"NM_030241.2"}}</span>NM_030241.2</a></td></tr><tr><td rowspan="1" colspan="1">Igfbp5</td><td rowspan="1" colspan="1">Insulin-like growth factor binding protein 5</td><td rowspan="1" colspan="1">1.37</td><td rowspan="1" colspan="1">0.000</td><td rowspan="1" colspan="1"><a id="__tag_362115924" class="tag_hotlink" href="/nuccore/NM_010518" ref="/nuccore/NM_010518"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_010518","term_id":"70909321","term_text":"NM_010518"}}</span>NM_010518</a></td></tr><tr><td rowspan="1" colspan="1">Mllt3</td><td rowspan="1" colspan="1">Myeloid/lymphoid or mixed lineage-leukemia translocation to 3 homolog (Drosophila), transcript variant 2</td><td rowspan="1" colspan="1">1.36</td><td rowspan="1" colspan="1">0.008</td><td rowspan="1" colspan="1"><a id="__tag_362115866" class="tag_hotlink" href="/nuccore/NM_029931.2" ref="/nuccore/NM_029931.2"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_029931.2","term_id":"114205403","term_text":"NM_029931.2"}}</span>NM_029931.2</a></td></tr><tr><td rowspan="1" colspan="1">Zbtb12</td><td rowspan="1" colspan="1">Zinc finger and BTB domain containing 12</td><td rowspan="1" colspan="1">1.35</td><td rowspan="1" colspan="1">0.012</td><td rowspan="1" colspan="1"><a id="__tag_362115897" class="tag_hotlink" href="/nuccore/NM_198886.2" ref="/nuccore/NM_198886.2"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_198886.2","term_id":"40254419","term_text":"NM_198886.2"}}</span>NM_198886.2</a></td></tr><tr><td rowspan="1" colspan="1">Smarcd3</td><td rowspan="1" colspan="1">SWI/SNF related, matrix associated, actin-dependent regulator of chromatin, subfamily d, member 3</td><td rowspan="1" colspan="1">1.35</td><td rowspan="1" colspan="1">0.006</td><td rowspan="1" colspan="1"><a id="__tag_362115853" class="tag_hotlink" href="/nuccore/NM_025891.3" ref="/nuccore/NM_025891.3"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_025891.3","term_id":"77404372","term_text":"NM_025891.3"}}</span>NM_025891.3</a></td></tr><tr><td rowspan="1" colspan="1">Hdac4</td><td rowspan="1" colspan="1">Histone deacetylase 4</td><td rowspan="1" colspan="1">1.35</td><td rowspan="1" colspan="1">0.000</td><td rowspan="1" colspan="1"><a id="__tag_362115911" class="tag_hotlink" href="/nuccore/NM_207225.1" ref="/nuccore/NM_207225.1"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_207225.1","term_id":"46402200","term_text":"NM_207225.1"}}</span>NM_207225.1</a></td></tr><tr><td rowspan="1" colspan="1">Eif3s2</td><td rowspan="1" colspan="1">Eukaryotic translation initiation factor 3, subunit 2 (beta)</td><td rowspan="1" colspan="1">1.35</td><td rowspan="1" colspan="1">0.002</td><td rowspan="1" colspan="1"><a id="__tag_362115905" class="tag_hotlink" href="/nuccore/NM_018799.1" ref="/nuccore/NM_018799.1"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_018799.1","term_id":"9055369","term_text":"NM_018799.1"}}</span>NM_018799.1</a></td></tr><tr><td rowspan="1" colspan="1">St3gal2</td><td rowspan="1" colspan="1">ST3 beta-galactoside alpha-2,3-sialyltransferase 2, transcript variant 2</td><td rowspan="1" colspan="1">1.34</td><td rowspan="1" colspan="1">0.006</td><td rowspan="1" colspan="1"><a id="__tag_362115902" class="tag_hotlink" href="/nuccore/NM_178048.2" ref="/nuccore/NM_178048.2"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_178048.2","term_id":"31341604","term_text":"NM_178048.2"}}</span>NM_178048.2</a></td></tr><tr><td rowspan="1" colspan="1">Slc25a15</td><td rowspan="1" colspan="1">Solute carrier family 25 (mitochondrial carrier ornithine transporter), member 15</td><td rowspan="1" colspan="1">1.34</td><td rowspan="1" colspan="1">0.000</td><td rowspan="1" colspan="1"><a id="__tag_362115872" class="tag_hotlink" href="/nuccore/NM_181325.2" ref="/nuccore/NM_181325.2"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_181325.2","term_id":"31342188","term_text":"NM_181325.2"}}</span>NM_181325.2</a></td></tr><tr><td rowspan="1" colspan="1">Klc2</td><td rowspan="1" colspan="1">Kinesin light chain 2</td><td rowspan="1" colspan="1">1.34</td><td rowspan="1" colspan="1">0.007</td><td rowspan="1" colspan="1"><a id="__tag_362115882" class="tag_hotlink" href="/nuccore/NM_008451" ref="/nuccore/NM_008451"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_008451","term_id":"133778982","term_text":"NM_008451"}}</span>NM_008451</a></td></tr><tr><td rowspan="1" colspan="1">Epdr1</td><td rowspan="1" colspan="1">Ependymin-related protein 1</td><td rowspan="1" colspan="1">1.34</td><td rowspan="1" colspan="1">0.012</td><td rowspan="1" colspan="1"><a id="__tag_362115892" class="tag_hotlink" href="/nuccore/NM_134065.2" ref="/nuccore/NM_134065.2"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_134065.2","term_id":"31542611","term_text":"NM_134065.2"}}</span>NM_134065.2</a></td></tr><tr><td rowspan="1" colspan="1">Slc11a2</td><td rowspan="1" colspan="1">Solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2</td><td rowspan="1" colspan="1">1.34</td><td rowspan="1" colspan="1">0.010</td><td rowspan="1" colspan="1"><a id="__tag_362115909" class="tag_hotlink" href="/nuccore/AK049856" ref="/nuccore/AK049856"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AK049856","term_id":"26340595","term_text":"AK049856"}}</span>AK049856</a></td></tr><tr><td rowspan="1" colspan="1">Abca15</td><td rowspan="1" colspan="1">ATP-binding cassette, subfamily A (ABC1), member 15</td><td rowspan="1" colspan="1">1.34</td><td rowspan="1" colspan="1">0.006</td><td rowspan="1" colspan="1"><a id="__tag_362115861" class="tag_hotlink" href="/nuccore/NM_177213.3" ref="/nuccore/NM_177213.3"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_177213.3","term_id":"46358377","term_text":"NM_177213.3"}}</span>NM_177213.3</a></td></tr><tr><td rowspan="1" colspan="1">Pip5k2b</td><td rowspan="1" colspan="1">Predicted: phosphatidylinositol-4-phosphate 5-kinase, type II, beta, transcript variant 4</td><td rowspan="1" colspan="1">1.33</td><td rowspan="1" colspan="1">0.003</td><td rowspan="1" colspan="1"><a id="__tag_362115871" class="tag_hotlink" href="/nuccore/XM_991639.1" ref="/nuccore/XM_991639.1"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"XM_991639.1","term_id":"94390629","term_text":"XM_991639.1"}}</span>XM_991639.1</a></td></tr><tr><td rowspan="1" colspan="1">Ptp4a2</td><td rowspan="1" colspan="1">Protein tyrosine phosphatase 4a2</td><td rowspan="1" colspan="1">1.33</td><td rowspan="1" colspan="1">0.003</td><td rowspan="1" colspan="1"><a id="__tag_362115845" class="tag_hotlink" href="/nuccore/NM_008974.3" ref="/nuccore/NM_008974.3"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_008974.3","term_id":"56711341","term_text":"NM_008974.3"}}</span>NM_008974.3</a></td></tr><tr><td rowspan="1" colspan="1">Col11a2</td><td rowspan="1" colspan="1">Procollagen, type XI, alpha 2</td><td rowspan="1" colspan="1">1.33</td><td rowspan="1" colspan="1">0.006</td><td rowspan="1" colspan="1"><a id="__tag_362115877" class="tag_hotlink" href="/nuccore/NM_009926.1" ref="/nuccore/NM_009926.1"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_009926.1","term_id":"6753481","term_text":"NM_009926.1"}}</span>NM_009926.1</a></td></tr><tr><td rowspan="1" colspan="1">Prkcq</td><td rowspan="1" colspan="1">Protein kinase C, theta</td><td rowspan="1" colspan="1">1.32</td><td rowspan="1" colspan="1">0.014</td><td rowspan="1" colspan="1"><a id="__tag_362115857" class="tag_hotlink" href="/nuccore/NM_008859.2" ref="/nuccore/NM_008859.2"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_008859.2","term_id":"118130636","term_text":"NM_008859.2"}}</span>NM_008859.2</a></td></tr><tr><td rowspan="1" colspan="1">Ssbp2</td><td rowspan="1" colspan="1">Single-stranded DNA-binding protein 2</td><td rowspan="1" colspan="1">1.32</td><td rowspan="1" colspan="1">0.012</td><td rowspan="1" colspan="1"><a id="__tag_362115870" class="tag_hotlink" href="/nuccore/NM_024186.1" ref="/nuccore/NM_024186.1"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_024186.1","term_id":"18859588","term_text":"NM_024186.1"}}</span>NM_024186.1</a></td></tr></tbody></table></div><div id="largeobj_idm140662071382960" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2910057/table/T2/?report=objectonly">Open in a separate window</a></div></div><p id="__p24" class="p p-last">Interrogation of differentially expressed genes on the Ingenuity platform identified that a subset of differentially expressed genes in Tg-ROR&#x003b1;1&#x00394;DE mice were involved in/associated with lipid metabolism, small molecule transport and biochemistry, cardiovascular and metabolic disease, carbohydrate metabolism, endocrine system disorders etc (see <a href="http://nar.oxfordjournals.org/cgi/content/full/gkq180/DC1" ref="reftype=extlink&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">Supplementary Figure S4</a>), in concordance with the pathophysiological role of NRs. The majority of metabolic genes are down regulated in the major functional categories of lipid and carbohydrate metabolism (<a href="http://nar.oxfordjournals.org/cgi/content/full/gkq180/DC1" ref="reftype=extlink&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">Supplementary Figure S4</a> and <a href="http://nar.oxfordjournals.org/cgi/content/full/gkq180/DC1" ref="reftype=extlink&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">S5</a>). This is consistent with several investigations in ROR&#x003b1; deficient mouse models (<a href="#B2" rid="B2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115674">2</a>,<a href="#B8" rid="B8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115665">8</a>). In the framework of this investigation, the primary signaling pathways regulated in skeletal muscle were the glutathione metabolism (responsible for the tight control of ROS levels, which modulate insulin sensitivity), type 2 diabetic signaling and fatty acid biosynthesis. Notably, several NR signaling (and RXR-dependent) pathways including LXR, FXR VDR and PXR were identified in the analysis. The higher ranked NR signaling pathways control lipogenesis/fatty acid biosynthesis (LXR) and cholesterol homeostasis (LXR and FXR) in agreement with the functional annotation (see <a href="http://nar.oxfordjournals.org/cgi/content/full/gkq180/DC1" ref="reftype=extlink&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">Supplementary Data S4</a> and <a href="http://nar.oxfordjournals.org/cgi/content/full/gkq180/DC1" ref="reftype=extlink&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">S5</a>). The majority of differentially expressed genes were associated with lipid/carbohydrate metabolism and metabolic disease (<a href="http://nar.oxfordjournals.org/cgi/content/full/gkq180/DC1" ref="reftype=extlink&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">Supplementary Data S5A</a>).</p></div><div id="__sec16" class="sec"><h3>Expression of the truncated orphan nuclear receptor, ROR&#x003b1;, affected the fatty acid biosynthetic pathway: decreased SREBP-1c, LXR&#x003b1; and downstream target genes in Tg-ROR&#x003b1;1&#x00394;DE mice</h3><p id="__p25" class="p p-first">Previously we have demonstrated that staggerer mice (<em>sg</em>/<em>sg</em>), with decreased and dysfunctional ROR&#x003b1; expression (in all organs) are resistant to (high fat) diet induced obesity (<a href="#B8" rid="B8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115697">8</a>). The genes, pathways and functional role identified (for ROR&#x003b1;) from the interrogation of the data revealed that lipid metabolism (especially fatty acid biosynthesis/lipogenesis) functions and pathways were highly ranked. We have validated the illumina/genespring analysis by rigorous qPCR analysis utilizing a custom-designed ABI microfluidic TLDA, that encoded taqman primer sets for critical metabolic genes involved in the control of lipid homeostasis. Specifically, in the context of lipogenic gene expression, TLDA analysis revealed significant differential expression (normalized against 18S rRNA) of the mRNAs encoding acyl-CoA synthetase long chain family member 4 (ACSL4), fatty acid translocase/cluster of differentiation 36 (FAT/CD36), fatty acid synthase (FAS), stearyl-coA dehydrogenase 1 (SCD-1), SREBP-1c and many other genes in the skeletal muscle of male Tg-ROR&#x003b1;1&#x00394;DE mice relative to wild-type littermates (assigned by the Empirical Bayes statistic, see <a href="/pmc/articles/PMC2910057/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>, <a href="http://nar.oxfordjournals.org/cgi/content/full/gkq180/DC1" ref="reftype=extlink&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">Supplementary Data S6</a>&#x02014;<a href="http://nar.oxfordjournals.org/cgi/content/full/gkq180/DC1" ref="reftype=extlink&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">Supplementary Figure S6</a> shows the complete list). Stringent filtering of data using the Benjamini&#x02013;Hochberg method to control <em>P</em> value false discovery rate (FDR) refined the significant subset of differentially expressed genes to SREBP-1c, FAS, SCD-1, ACSL4, CD36 and HIF1&#x003b1; (<a href="/pmc/articles/PMC2910057/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a>A and <a href="/pmc/articles/PMC2910057/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>).

</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC2910057/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140662071811872" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2910057_gkq180f2.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is gkq180f2.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2910057/bin/gkq180f2.jpg" /></a></div><div id="largeobj_idm140662071811872" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2910057/figure/F2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC2910057/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2.</a></div><!--caption a7--><div class="caption"><p id="__p26">Graphs showing significant changes in expression of lipogenic genes in the skeletal muscle of transgenic mice. (<strong>A</strong>) Data derived from <a href="/pmc/articles/PMC2910057/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a> are expressed as fold change (log<sub>10</sub>) normalized to 18S mRNA, following application of Benjamini&#x02013;Hochberg false detection rate algorithm. qPCR of (<strong>B</strong>) LXR&#x003b1;, (<strong>C</strong>) Tip47 and (<strong>D</strong>) Dgat2 in skeletal muscle of transgenic and wt littermate control mice. Relative fold change is normalized against 18S mRNA (<em>n</em> = 6/group, mean &#x000b1; SEM. *<em>P</em> &#x0003c; 0.05, **<em>P</em> &#x02264; 0.01 ***<em>P</em> &#x02264; 0.001). (<strong>E</strong>) Graphs showing significant changes in expression of the entire NR gene superfamily in the skeletal muscle of transgenic mice. Data derived from <a href="/pmc/articles/PMC2910057/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a> and S7 are expressed as fold change (log10) after normalization against the median of three genorm-selected controls GAPDH, gusB and Hprt1 following application of Benjamini&#x02013;Hochberg false detection rate algorithm.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T3"><h3>Table 3.</h3><!--caption a7--><div class="caption"><p id="__p27">Relative quantification of gene expression in skeletal muscle of transgenic compared to wt littermate controls</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140662109402160" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead align="left"><tr><th rowspan="1" colspan="1">Entrez gene symbol- TaqMan assay ID</th><th rowspan="1" colspan="1">&#x00394;&#x00394;<em>C</em><sub>t</sub></th><th rowspan="1" colspan="1"><em>P</em>-value</th><th rowspan="1" colspan="1"><em>B</em>-value</th><th rowspan="1" colspan="1"><em>t-</em>value</th><th rowspan="1" colspan="1">RQ. Log<sub>10</sub></th><th rowspan="1" colspan="1">RQ. Linear</th><th rowspan="1" colspan="1">Significance</th><th rowspan="1" colspan="1">Adj. <em>P</em>-value</th><th rowspan="1" colspan="1">Significance FDR</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">Lipogenesis<sup>a</sup></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Abca1-Mm00442646_m1</td><td rowspan="1" colspan="1">0.628</td><td rowspan="1" colspan="1">0.038</td><td rowspan="1" colspan="1">&#x02212;4.081</td><td rowspan="1" colspan="1">2.283</td><td rowspan="1" colspan="1">&#x02212;0.189</td><td rowspan="1" colspan="1">0.647</td><td rowspan="1" colspan="1">Significant</td><td rowspan="1" colspan="1">0.080</td><td rowspan="1" colspan="1">NS</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<strong>Acsl4-Mm00490331_m1</strong></td><td rowspan="1" colspan="1"><strong>1.396</strong></td><td rowspan="1" colspan="1"><strong>0.001</strong></td><td rowspan="1" colspan="1"><strong>&#x02212;0.313</strong></td><td rowspan="1" colspan="1"><strong>4.273</strong></td><td rowspan="1" colspan="1"><strong>&#x02212;0.420</strong></td><td rowspan="1" colspan="1"><strong>0.380</strong></td><td rowspan="1" colspan="1"><strong>Significant</strong></td><td rowspan="1" colspan="1"><strong>0.012</strong></td><td rowspan="1" colspan="1"><strong>Significant</strong></td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Cav3-Mm01182632_m1</td><td rowspan="1" colspan="1">0.452</td><td rowspan="1" colspan="1">0.043</td><td rowspan="1" colspan="1">&#x02212;4.190</td><td rowspan="1" colspan="1">2.220</td><td rowspan="1" colspan="1">&#x02212;0.136</td><td rowspan="1" colspan="1">0.731</td><td rowspan="1" colspan="1">Significant</td><td rowspan="1" colspan="1">0.081</td><td rowspan="1" colspan="1">NS</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<strong>Cd36-Mm00432403_m1</strong></td><td rowspan="1" colspan="1"><strong>1.115</strong></td><td rowspan="1" colspan="1"><strong>0.013</strong></td><td rowspan="1" colspan="1"><strong>&#x02212;3.121</strong></td><td rowspan="1" colspan="1"><strong>2.814</strong></td><td rowspan="1" colspan="1"><strong>&#x02212;0.335</strong></td><td rowspan="1" colspan="1"><strong>0.462</strong></td><td rowspan="1" colspan="1"><strong>Significant</strong></td><td rowspan="1" colspan="1"><strong>0.042</strong></td><td rowspan="1" colspan="1"><strong>Significant</strong></td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Cebpb-Mm00843434_s1</td><td rowspan="1" colspan="1">0.908</td><td rowspan="1" colspan="1">0.023</td><td rowspan="1" colspan="1">&#x02212;3.614</td><td rowspan="1" colspan="1">2.546</td><td rowspan="1" colspan="1">&#x02212;0.273</td><td rowspan="1" colspan="1">0.533</td><td rowspan="1" colspan="1">Significant</td><td rowspan="1" colspan="1">0.061</td><td rowspan="1" colspan="1">NS</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Cebpd-Mm00786711_s1</td><td rowspan="1" colspan="1">1.086</td><td rowspan="1" colspan="1">0.029</td><td rowspan="1" colspan="1">&#x02212;3.827</td><td rowspan="1" colspan="1">2.428</td><td rowspan="1" colspan="1">&#x02212;0.327</td><td rowspan="1" colspan="1">0.471</td><td rowspan="1" colspan="1">Significant</td><td rowspan="1" colspan="1">0.068</td><td rowspan="1" colspan="1">NS</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<strong>Fasn-Mm00662319_m1</strong></td><td rowspan="1" colspan="1"><strong>1.844</strong></td><td rowspan="1" colspan="1"><strong>0.005</strong></td><td rowspan="1" colspan="1"><strong>&#x02212;2.163</strong></td><td rowspan="1" colspan="1"><strong>3.316</strong></td><td rowspan="1" colspan="1"><strong>&#x02212;0.555</strong></td><td rowspan="1" colspan="1"><strong>0.279</strong></td><td rowspan="1" colspan="1"><strong>Significant</strong></td><td rowspan="1" colspan="1"><strong>0.023</strong></td><td rowspan="1" colspan="1"><strong>Significant</strong></td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<strong>Hif1a-Mm00468875_m1</strong></td><td rowspan="1" colspan="1"><strong>0.797</strong></td><td rowspan="1" colspan="1"><strong>0.013</strong></td><td rowspan="1" colspan="1"><strong>&#x02212;3.082</strong></td><td rowspan="1" colspan="1"><strong>2.834</strong></td><td rowspan="1" colspan="1"><strong>&#x02212;0.240</strong></td><td rowspan="1" colspan="1"><strong>0.575</strong></td><td rowspan="1" colspan="1"><strong>Significant</strong></td><td rowspan="1" colspan="1"><strong>0.042</strong></td><td rowspan="1" colspan="1"><strong>Significant</strong></td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<strong>Scd1-Mm00772290_m1</strong></td><td rowspan="1" colspan="1"><strong>2.099</strong></td><td rowspan="1" colspan="1"><strong>0.001</strong></td><td rowspan="1" colspan="1"><strong>&#x02212;0.881</strong></td><td rowspan="1" colspan="1"><strong>3.978</strong></td><td rowspan="1" colspan="1"><strong>&#x02212;0.632</strong></td><td rowspan="1" colspan="1"><strong>0.233</strong></td><td rowspan="1" colspan="1"><strong>Significant</strong></td><td rowspan="1" colspan="1"><strong>0.012</strong></td><td rowspan="1" colspan="1"><strong>Significant</strong></td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<strong>Srebf1-Mm00550338_m1</strong></td><td rowspan="1" colspan="1"><strong>0.764</strong></td><td rowspan="1" colspan="1"><strong>0.004</strong></td><td rowspan="1" colspan="1"><strong>&#x02212;2.034</strong></td><td rowspan="1" colspan="1"><strong>3.383</strong></td><td rowspan="1" colspan="1"><strong>&#x02212;0.230</strong></td><td rowspan="1" colspan="1"><strong>0.589</strong></td><td rowspan="1" colspan="1"><strong>Significant</strong></td><td rowspan="1" colspan="1"><strong>0.023</strong></td><td rowspan="1" colspan="1"><strong>Significant</strong></td></tr><tr><td rowspan="1" colspan="1">Nuclear receptors<sup>b</sup></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Nr1h3-Mm00443454_m1</td><td rowspan="1" colspan="1">0.814</td><td rowspan="1" colspan="1">0.039</td><td rowspan="1" colspan="1">&#x02212;3.531</td><td rowspan="1" colspan="1">2.522</td><td rowspan="1" colspan="1">&#x02212;0.245</td><td rowspan="1" colspan="1">0.569</td><td rowspan="1" colspan="1">Significant</td><td rowspan="1" colspan="1">0.393</td><td rowspan="1" colspan="1">NS</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Nr2c1-Mm00449123_m1</td><td rowspan="1" colspan="1">0.601</td><td rowspan="1" colspan="1">0.032</td><td rowspan="1" colspan="1">&#x02212;3.353</td><td rowspan="1" colspan="1">2.661</td><td rowspan="1" colspan="1">&#x02212;0.181</td><td rowspan="1" colspan="1">0.659</td><td rowspan="1" colspan="1">Significant</td><td rowspan="1" colspan="1">0.393</td><td rowspan="1" colspan="1">NS</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Nr3c1-Mm00433832_m1</td><td rowspan="1" colspan="1">0.912</td><td rowspan="1" colspan="1">0.005</td><td rowspan="1" colspan="1">&#x02212;1.734</td><td rowspan="1" colspan="1">4.037</td><td rowspan="1" colspan="1">&#x02212;0.275</td><td rowspan="1" colspan="1">0.531</td><td rowspan="1" colspan="1">Significant</td><td rowspan="1" colspan="1">0.234</td><td rowspan="1" colspan="1">NS</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Ppard-Mm00803186_g1</td><td rowspan="1" colspan="1">0.926</td><td rowspan="1" colspan="1">0.041</td><td rowspan="1" colspan="1">&#x02212;3.564</td><td rowspan="1" colspan="1">2.496</td><td rowspan="1" colspan="1">&#x02212;0.279</td><td rowspan="1" colspan="1">0.526</td><td rowspan="1" colspan="1">Significant</td><td rowspan="1" colspan="1">0.393</td><td rowspan="1" colspan="1">NS</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Rorc-Mm00441139_m1</td><td rowspan="1" colspan="1">0.860</td><td rowspan="1" colspan="1">0.019</td><td rowspan="1" colspan="1">&#x02212;2.911</td><td rowspan="1" colspan="1">3.013</td><td rowspan="1" colspan="1">&#x02212;0.259</td><td rowspan="1" colspan="1">0.551</td><td rowspan="1" colspan="1">Significant</td><td rowspan="1" colspan="1">0.393</td><td rowspan="1" colspan="1">NS</td></tr><tr><td rowspan="1" colspan="1">Glucose homeostasis<sup>a</sup></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<strong>Akt2-Mm00545827_m1</strong></td><td rowspan="1" colspan="1"><strong>1.684</strong></td><td rowspan="1" colspan="1"><strong>0.001</strong></td><td rowspan="1" colspan="1"><strong>&#x02212;0.621</strong></td><td rowspan="1" colspan="1"><strong>4.337</strong></td><td rowspan="1" colspan="1"><strong>&#x02212;0.507</strong></td><td rowspan="1" colspan="1"><strong>0.311</strong></td><td rowspan="1" colspan="1"><strong>Significant</strong></td><td rowspan="1" colspan="1"><strong>0.037</strong></td><td rowspan="1" colspan="1"><strong>Significant</strong></td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Cs- Mm00466043_m1</td><td rowspan="1" colspan="1">0.515</td><td rowspan="1" colspan="1">0.011</td><td rowspan="1" colspan="1">&#x02212;2.781</td><td rowspan="1" colspan="1">3.061</td><td rowspan="1" colspan="1">&#x02212;0.155</td><td rowspan="1" colspan="1">0.700</td><td rowspan="1" colspan="1">Significant</td><td rowspan="1" colspan="1">0.087</td><td rowspan="1" colspan="1">NS</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Foxo1-Mm00490672_m1</td><td rowspan="1" colspan="1">1.229</td><td rowspan="1" colspan="1">0.042</td><td rowspan="1" colspan="1">&#x02212;4.074</td><td rowspan="1" colspan="1">2.295</td><td rowspan="1" colspan="1">&#x02212;0.370</td><td rowspan="1" colspan="1">0.427</td><td rowspan="1" colspan="1">Significant</td><td rowspan="1" colspan="1">0.173</td><td rowspan="1" colspan="1">NS</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Il15-Mm00434210_m1</td><td rowspan="1" colspan="1">1.076</td><td rowspan="1" colspan="1">0.026</td><td rowspan="1" colspan="1">&#x02212;3.634</td><td rowspan="1" colspan="1">2.561</td><td rowspan="1" colspan="1">&#x02212;0.324</td><td rowspan="1" colspan="1">0.474</td><td rowspan="1" colspan="1">Significant</td><td rowspan="1" colspan="1">0.132</td><td rowspan="1" colspan="1">NS</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Lepr-Mm00440181_m1</td><td rowspan="1" colspan="1">1.173</td><td rowspan="1" colspan="1">0.009</td><td rowspan="1" colspan="1">&#x02212;2.664</td><td rowspan="1" colspan="1">3.129</td><td rowspan="1" colspan="1">&#x02212;0.353</td><td rowspan="1" colspan="1">0.443</td><td rowspan="1" colspan="1">Significant</td><td rowspan="1" colspan="1">0.087</td><td rowspan="1" colspan="1">NS</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Pdk3-Mm00455220_m1</td><td rowspan="1" colspan="1">1.071</td><td rowspan="1" colspan="1">0.028</td><td rowspan="1" colspan="1">&#x02212;3.703</td><td rowspan="1" colspan="1">2.520</td><td rowspan="1" colspan="1">&#x02212;0.323</td><td rowspan="1" colspan="1">0.476</td><td rowspan="1" colspan="1">Significant</td><td rowspan="1" colspan="1">0.132</td><td rowspan="1" colspan="1">NS</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Pdk4-Mm00443325_m1</td><td rowspan="1" colspan="1">0.887</td><td rowspan="1" colspan="1">0.018</td><td rowspan="1" colspan="1">&#x02212;3.293</td><td rowspan="1" colspan="1">2.763</td><td rowspan="1" colspan="1">&#x02212;0.267</td><td rowspan="1" colspan="1">0.541</td><td rowspan="1" colspan="1">Significant</td><td rowspan="1" colspan="1">0.119</td><td rowspan="1" colspan="1">NS</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Stat5b-Mm00839889_m1</td><td rowspan="1" colspan="1">0.892</td><td rowspan="1" colspan="1">0.003</td><td rowspan="1" colspan="1">&#x02212;1.646</td><td rowspan="1" colspan="1">3.723</td><td rowspan="1" colspan="1">&#x02212;0.269</td><td rowspan="1" colspan="1">0.539</td><td rowspan="1" colspan="1">Significant</td><td rowspan="1" colspan="1">0.053</td><td rowspan="1" colspan="1">NS</td></tr><tr><td rowspan="1" colspan="1">Myogenesis<sup>a</sup></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Acvr2a-Mm00431657_m1</td><td rowspan="1" colspan="1">0.616</td><td rowspan="1" colspan="1">0.029</td><td rowspan="1" colspan="1">&#x02212;3.719</td><td rowspan="1" colspan="1">2.502</td><td rowspan="1" colspan="1">&#x02212;0.185</td><td rowspan="1" colspan="1">0.653</td><td rowspan="1" colspan="1">Significant</td><td rowspan="1" colspan="1">0.123</td><td rowspan="1" colspan="1">NS</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Gdf8-Mm00440328_m1</td><td rowspan="1" colspan="1">0.888</td><td rowspan="1" colspan="1">0.047</td><td rowspan="1" colspan="1">&#x02212;4.155</td><td rowspan="1" colspan="1">2.234</td><td rowspan="1" colspan="1">&#x02212;0.267</td><td rowspan="1" colspan="1">0.540</td><td rowspan="1" colspan="1">Significant</td><td rowspan="1" colspan="1">0.141</td><td rowspan="1" colspan="1">NS</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<strong>Hdac5-Mm00515917_m1</strong></td><td rowspan="1" colspan="1"><strong>0.599</strong></td><td rowspan="1" colspan="1"><strong>0.001</strong></td><td rowspan="1" colspan="1"><strong>&#x02212;0.721</strong></td><td rowspan="1" colspan="1"><strong>4.283</strong></td><td rowspan="1" colspan="1"><strong>&#x02212;0.180</strong></td><td rowspan="1" colspan="1"><strong>0.660</strong></td><td rowspan="1" colspan="1"><strong>Significant</strong></td><td rowspan="1" colspan="1"><strong>0.026</strong></td><td rowspan="1" colspan="1"><strong>Significant</strong></td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Mef2a-Mm00488969_m1</td><td rowspan="1" colspan="1">0.397</td><td rowspan="1" colspan="1">0.042</td><td rowspan="1" colspan="1">&#x02212;4.061</td><td rowspan="1" colspan="1">2.293</td><td rowspan="1" colspan="1">&#x02212;0.119</td><td rowspan="1" colspan="1">0.760</td><td rowspan="1" colspan="1">Significant</td><td rowspan="1" colspan="1">0.140</td><td rowspan="1" colspan="1">NS</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Mef2d-Mm00504929_m1</td><td rowspan="1" colspan="1">0.499</td><td rowspan="1" colspan="1">0.021</td><td rowspan="1" colspan="1">&#x02212;3.398</td><td rowspan="1" colspan="1">2.693</td><td rowspan="1" colspan="1">&#x02212;0.150</td><td rowspan="1" colspan="1">0.708</td><td rowspan="1" colspan="1">Significant</td><td rowspan="1" colspan="1">0.114</td><td rowspan="1" colspan="1">NS</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Smad1-Mm00484721_m1</td><td rowspan="1" colspan="1">0.503</td><td rowspan="1" colspan="1">0.034</td><td rowspan="1" colspan="1">&#x02212;3.847</td><td rowspan="1" colspan="1">2.424</td><td rowspan="1" colspan="1">&#x02212;0.151</td><td rowspan="1" colspan="1">0.706</td><td rowspan="1" colspan="1">Significant</td><td rowspan="1" colspan="1">0.123</td><td rowspan="1" colspan="1">NS</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Smad2-Mm00487530_m1</td><td rowspan="1" colspan="1">0.701</td><td rowspan="1" colspan="1">0.011</td><td rowspan="1" colspan="1">&#x02212;2.793</td><td rowspan="1" colspan="1">3.050</td><td rowspan="1" colspan="1">&#x02212;0.211</td><td rowspan="1" colspan="1">0.615</td><td rowspan="1" colspan="1">Significant</td><td rowspan="1" colspan="1">0.087</td><td rowspan="1" colspan="1">NS</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<strong>Tgfbr1-Mm00436971_m1</strong></td><td rowspan="1" colspan="1"><strong>1.296</strong></td><td rowspan="1" colspan="1"><strong>0.002</strong></td><td rowspan="1" colspan="1"><strong>&#x02212;0.925</strong></td><td rowspan="1" colspan="1"><strong>4.157</strong></td><td rowspan="1" colspan="1"><strong>&#x02212;0.390</strong></td><td rowspan="1" colspan="1"><strong>0.407</strong></td><td rowspan="1" colspan="1"><strong>Significant</strong></td><td rowspan="1" colspan="1"><strong>0.026</strong></td><td rowspan="1" colspan="1"><strong>Significant</strong></td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Tgfbr2-Mm00436978_m1</td><td rowspan="1" colspan="1">0.675</td><td rowspan="1" colspan="1">0.013</td><td rowspan="1" colspan="1">&#x02212;2.977</td><td rowspan="1" colspan="1">2.941</td><td rowspan="1" colspan="1">&#x02212;0.203</td><td rowspan="1" colspan="1">0.626</td><td rowspan="1" colspan="1">Significant</td><td rowspan="1" colspan="1">0.087</td><td rowspan="1" colspan="1">NS</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Tnni2-Mm00437157_g1</td><td rowspan="1" colspan="1">0.510</td><td rowspan="1" colspan="1">0.009</td><td rowspan="1" colspan="1">&#x02212;2.561</td><td rowspan="1" colspan="1">3.185</td><td rowspan="1" colspan="1">&#x02212;0.154</td><td rowspan="1" colspan="1">0.702</td><td rowspan="1" colspan="1">Significant</td><td rowspan="1" colspan="1">0.087</td><td rowspan="1" colspan="1">NS</td></tr></tbody></table></div><div id="largeobj_idm140662109402160" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2910057/table/T3/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TF1"><p id="__p28" class="p p-first-last">Significance was assigned by the application of the Empirical Bayes statistic. RQ, relative quantification; FDR, false detection rate; NS, not significant. Bold text denotes significant changes in gene expression after more conservative data filtering (Benjamini-Hochberg) to control for false discovery rate, and correct <em>P</em>-values.</p></div><div id="TF2"><p id="__p29" class="p p-first-last"><sup>a</sup>Target genes normalized to 18S RNA.</p></div><div id="TF3"><p id="__p30" class="p p-first-last"><sup>b</sup>Target genes normalized to gusB, hprt1 and gapdh.</p></div></div></div><p id="__p31">Subsequently, we used (manual) qPCR to examine (and validate) the expression of several other genes in the lipogenic pathway that were identified in the illumina analysis as significant, differentially expressed targets. The Tg-ROR&#x003b1;1&#x00394;DE mice also displayed significantly reduced expression of the mRNAs encoding the nuclear hormone receptor, LXR&#x003b1; (<a href="/pmc/articles/PMC2910057/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a>B), a critical transcriptional regulator of SREBP-1c and the genetic program that regulates lipogenesis. Interestingly, the expression of both FAS and SCD-1 (responsible for the synthesis of <em>de novo</em> fatty acids and monounsaturated fatty acids, respectively) was also decreased. These genes are downstream targets of LXR&#x003b1; and SREBP1c (the master transcriptional regulators of the genetic program that modulates lipogenesis). Moreover, these changes in gene expression were not observed in either liver or adipose tissue (data not shown).</p><p id="__p32">In addition, we analyzed several genes that are involved in intramuscular triglyceride (IMTG) accumulation. We identified that the expression of the two mRNAs encoding tail interacting protein (Tip47) and di-acyl glycerol acetyl transferase 2 (Dgat2) were significantly reduced in the male Tg-ROR&#x003b1;1&#x00394;DE transgenic mice relative to wild-type littermate pairs (<a href="/pmc/articles/PMC2910057/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a>C and D). In summary, we observed qPCR validation of the master transcriptional regulators of fatty acid biosynthesis (LXR and SREBP-1c) and several important downstream target genes (including FAS and SCD-1).</p><p id="__p33">The observation of attenuated LXR expression and decreased downstream target gene expression was consistent with the identification of this NR signaling cascade in the pathway analysis (<a href="http://nar.oxfordjournals.org/cgi/content/full/gkq180/DC1" ref="reftype=extlink&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">Supplementary Figures S4</a> and <a href="http://nar.oxfordjournals.org/cgi/content/full/gkq180/DC1" ref="reftype=extlink&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">S5</a>). We explored the NR signaling pathways more rigorously by performing qPCR analysis utilizing a custom-designed ABI microfluidic TLDA that encoded taqman primer sets targeting <em>all</em> 48 mouse NRs. The analysis revealed small, but significantly reduced (1.5&#x02013;2.5-fold) expression of the mRNAs encoding the nuclear hormone receptors: LXR&#x003b1;, TR2, PPAR&#x003b4;, GR and ROR&#x003b3; in the Tg-ROR&#x003b1;1&#x00394;DE mice, relative to the wt littermates (<a href="/pmc/articles/PMC2910057/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a>E, <a href="/pmc/articles/PMC2910057/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a> and <a href="http://nar.oxfordjournals.org/cgi/content/full/gkq180/DC1" ref="reftype=extlink&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">Supplementary Figure S7</a> shows the complete list of nuclear hormone receptors). Please note increased ROR&#x003b1; expression in the Tg-ROR&#x003b1;&#x00394;DE was not detected because the TLDA was mouse specific and the transgenic line expressed the truncated human transcript.</p><p id="__p34" class="p p-last">In summary, parallel analysis by illumina, ingenuity and qPCR on the TLDA platform have demonstrated that ROR&#x003b1; in skeletal muscle leads regulates the lipogenic/fatty acid biosynthetic pathway.</p></div><div id="__sec17" class="sec"><h3>Expression of truncated ROR&#x003b1; attenuated Akt (mRNA and protein) expression in Tg-ROR&#x003b1;1&#x00394;DE mice</h3><p id="__p35" class="p p-first">Pathway analysis revealed the involvement of ROR&#x003b1; expression in carbohydrate metabolism and type 2 diabetic signaling, and that truncated ROR&#x003b1; expression effected Akt2 mRNA levels (<a href="http://nar.oxfordjournals.org/cgi/content/full/gkq180/DC1" ref="reftype=extlink&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">Supplementary Figures S2</a>, <a href="http://nar.oxfordjournals.org/cgi/content/full/gkq180/DC1" ref="reftype=extlink&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">S4</a> and <a href="http://nar.oxfordjournals.org/cgi/content/full/gkq180/DC1" ref="reftype=extlink&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">S5A</a>). This led us to further examine the expression of critical genes involved in carbohydrate metabolism using the custom-designed ABI microfluidic TLDA to perform qPCR analysis. We identified statistically significant differential expression of several important genes that control insulin signaling and glucose uptake (<a href="/pmc/articles/PMC2910057/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>, <a href="http://nar.oxfordjournals.org/cgi/content/full/gkq180/DC1" ref="reftype=extlink&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">Supplementary Figure S8</a> shows the complete list of genes analyzed) in the Tg-ROR&#x003b1;1&#x00394;DE mice, relative to wild-type littermates. TLDA analysis revealed the expression of the mRNAs encoding Akt2, pyruvate dehydrogenase kinase isozyme 3 and 4 (Pdk3 and 4), and several other genes were significantly reduced in the skeletal muscle of male Tg-ROR&#x003b1;1&#x00394;DE mice relative to wild-type littermates (see <a href="/pmc/articles/PMC2910057/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>, <a href="http://nar.oxfordjournals.org/cgi/content/full/gkq180/DC1" ref="reftype=extlink&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">Supplementary Figure S8</a>. Subsequently, after correction/adjustment of <em>P</em> values according to the Benjamini&#x02013;Hochberg FDR method, Akt2 remained the only transcript that was significantly and differentially expressed (and repressed) in the Tg-ROR&#x003b1;1&#x00394;DE line (see <a href="/pmc/articles/PMC2910057/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>, <a href="http://nar.oxfordjournals.org/cgi/content/full/gkq180/DC1" ref="reftype=extlink&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">Supplementary Figure S8</a> and <a href="/pmc/articles/PMC2910057/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3</span></a>A). It should be noted that the data (prior to FDR filtering) has been derived from sensitive qPCR TLDA analysis from six littermate pairs of mice focused on metabolic genes. Assignment of significance prior to application of FDR analysis is relatively robust.
</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F3" co-legend-rid="lgnd_F3"><a href="/pmc/articles/PMC2910057/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140662065262096" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2910057_gkq180f3.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is gkq180f3.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2910057/bin/gkq180f3.jpg" /></a></div><div id="largeobj_idm140662065262096" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2910057/figure/F3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="/pmc/articles/PMC2910057/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">Figure 3.</a></div><!--caption a7--><div class="caption"><p id="__p36">(<strong>A</strong>) Graph showing a significant fold repression of Akt2 (RQ_Log10) in insulin-stimulated glucose uptake after stringent filtering of data by the application of Benjamini&#x02013;Hochberg false detection rate algorithm.In the skeletal muscle of transgenic mice relative wild-type mice. Data are derived from <a href="/pmc/articles/PMC2910057/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a> and is expressed as fold change (log<sub>10</sub>) normalized to 18S mRNA, following application of Benjamini&#x02013;Hochberg false detection rate algorithm (<em>n</em> = 6/group) (<strong>B</strong>) western blot analysis of Akt and pAkt in skeletal muscle of male transgenic mice and wt littermate control mice. Densitometry analysis of western blots (<strong>C</strong>) Akt and (<strong>D</strong>) pAkt (<em>n</em> = 3/group, mean &#x000b1; SEM. *<em>P</em> &#x0003c; 0.05, **<em>P</em> &#x02264; 0.01). (<strong>E</strong>) Body weight development in transgenic mice versus wt littermate controls over 14 weeks on normal chow diet (<em>n</em> = 19 male and <em>n</em> = 6 female, mean &#x000b1; SEM. *<em>P</em> &#x0003c; 0.05). (<strong>F</strong>) Plasma glucose levels of overnight fasted male transgenic and wt littermate control mice (<em>n</em> = 6/group, mean &#x000b1; SEM. *<em>P</em> &#x0003c; 0.05). (<strong>G</strong>) Blood glucose concentrations measured at various times after I/P administration of glucose (<em>t</em> = 0) to overnight fasted male transgenic and wt littermate control mice (<em>n</em> = 7/group, mean &#x000b1; SEM. *<em>P</em> &#x0003c; 0.05, **<em>P</em> &#x02264; 0.01). (<strong>H</strong>) Blood glucose concentrations measured at various times after IP administration of insulin (<em>t</em> = 0) to overnight fasted male transgenic and wt littermate control mice. Data are presented as percentage of starting blood glucose concentration at time = 0 (<em>I</em> = 7/group, mean &#x000b1; SEM).</p></div></div></div><p id="__p37" class="p p-last">Subsequently, we also assessed the expression of the other Akt family members. Although Akt2/PKB was significantly decreased in the skeletal muscle of male Tg-ROR&#x003b1;1&#x00394;DE mice relative to wild-type littermates, we observed no change in the expression of the mRNAs encoding, Akt1 or 3 (data not shown). Notably, no significant changes in gene expression were observed in either liver or adipose tissue after TLDA analysis (data not shown). In addition, we investigated whether attenuation in Akt2 mRNA expression correlated with changes in the protein levels of total Akt and phosphorylated (ser473) Akt/PKB using western analysis (<a href="/pmc/articles/PMC2910057/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3</span></a>B). We observed a significant decrease in total Akt/PKB protein in the Tg-ROR&#x003b1;1&#x00394;DE mice relative to wild-type littermate pairs (<a href="/pmc/articles/PMC2910057/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3</span></a>B and C), corresponding with the mRNA expression data. Moreover, the levels of the active phosphorylated (ser473) Akt species were also significantly decreased (<a href="/pmc/articles/PMC2910057/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3</span></a>B and D). Akt/PKB is a critical target in the regulation of GLUT4-[solute carrier family 2a (facilitated glucose transporter), member 4] mediated glucose uptake. In summation, corresponding investigation by illumina, qPCR (on the TLDA platform) and western analysis have demonstrated that ROR&#x003b1; in skeletal muscle regulates Akt2 mRNA, protein and phosphorylation. This is consistent with the high ranking of carbohydrate metabolism and type 2 diabetic signaling by the ingenuity platform.</p></div><div id="__sec18" class="sec"><h3>Expression of truncated ROR&#x003b1; in skeletal muscle induced mild hyperglycemia and glucose intolerance: attenuated insulin-mediated phosphorylation of Akt in the Tg-ROR&#x003b1;1&#x00394;DE mice</h3><p id="__p38" class="p p-first">Suppression of (total and phospho) Akt in skeletal muscle suggests the mouse model may display increased plasma glucose and impaired glucose tolerance. We conducted several experiments to characterize the phenotypic (and metabolic effects) of aberrant ROR&#x003b1; expression in skeletal muscle to validate the results of the illumina/ingenuity analysis.</p><p id="__p39">The transgenic mice presented with no gross or histological phenotypic abnormalities, although they did appear to be slightly smaller than their wt littermates. However, growth curve analysis from 4 to 14 weeks indicates that both male and female Tg-ROR&#x003b1;1&#x00394;DE mice on a regular chow diet showed no significant reductions in body weight, relative to wild-type littermate pairs (<a href="/pmc/articles/PMC2910057/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3</span></a>E). All subsequent studies were performed on male mice.</p><p id="__p40">We subsequently measured blood glucose and observed mild hyperglycemia in the transgenic mice, with increased fasting glucose levels in male transgenic mice relative to wild-type littermate pairs (<a href="/pmc/articles/PMC2910057/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3</span></a>F). This is consistent with decreased (total and phospho) Akt (mRNA and protein) levels in skeletal muscle. We further examined systemic glucose metabolism, and performed intraperitoneal glucose and insulin tolerance tests. In the Tg-ROR&#x003b1;1&#x00394;DE mice, glucose clearance was significantly delayed following a glucose challenge (<a href="/pmc/articles/PMC2910057/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3</span></a>G). No significant differences in plasma insulin levels between the transgenic and wt mice (on regular chow diets) were detected (data not shown). Furthermore, the glucose excursions displayed by Tg-ROR&#x003b1;1&#x00394;DE compared to wild-type mice during an insulin tolerance test were comparable (<a href="/pmc/articles/PMC2910057/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3</span></a>H). Moreover, no differences in plasma insulin concentration were observed either at baseline or ten minutes subsequent to glucose administration (data not shown).</p><p id="__p41">We subsequently examined whether skeletal muscle-specific expression of Tg-ROR&#x003b1;1&#x00394;DE mice played a role in insulin signaling. Protein extracts were isolated from saline and insulin injected (littermate pairs of) wt and Tg mice and subsequently analyzed by immunoblot analysis using Ab&#x02019;s specific to Akt2 and phospho- Akt2.</p><p id="__p42">Quantification of the western blots (<a href="/pmc/articles/PMC2910057/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4</span></a>E and F) demonstrated that there were no significant differences in (basal) total Akt2 levels in between saline and insulin-treated wild-type and Tg animals. As expected, insulin treatment in wild-type mice significantly stimulated the levels of phosphoS473Akt2 relative to saline treated mice (&#x0223c;3-fold <a href="/pmc/articles/PMC2910057/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4</span></a>A and B). However, we observed that insulin treatment did not significantly increase phosphorylation of Akt Ser473 in the male Tg-ROR&#x003b1;1&#x00394;DE mice (<a href="/pmc/articles/PMC2910057/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4</span></a>C and D, respectively).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F4" co-legend-rid="lgnd_F4"><a href="/pmc/articles/PMC2910057/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140662070957984" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2910057_gkq180f4.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is gkq180f4.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2910057/bin/gkq180f4.jpg" /></a></div><div id="largeobj_idm140662070957984" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2910057/figure/F4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F4"><div><a class="figpopup" href="/pmc/articles/PMC2910057/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4">Figure 4.</a></div><!--caption a7--><div class="caption"><p id="__p44">(<strong>A</strong>) and (<strong>B</strong>) Western blot and densitometry analysis of pAkt, total Akt and Gapdh in skeletal muscle of saline and insulin treated wild-type (wt) mice, respectively. (<strong>C</strong>) and (<strong>D</strong>) Western blot and densitometry analysis of pAkt, total Akt and Gapdh in skeletal muscle of saline and insulin-treated heterozygous transgenic-ROR&#x003b1;1&#x00394;DE mice, respectively. Briefly, fasted mice were IP injected with either saline or insulin (0.5 U/kg). Mice treated with saline (<em>n</em> = 4 wt and 4 tg) or insulin (<em>n</em> = 3 wt and 3 tg) was sacrificed after 10 min and skeletal muscle (quadricep) was excised and snap frozen. Densitometry expressed as the mean +/&#x02212; SEM, ***<em>P</em> &#x0003c; 0.001 (<strong>E</strong>) <em>Ex-vivo</em> insulin-stimulated glucose uptake in type II glycolytic muscle of wt and transgenic-ROR&#x003b1;1&#x00394;DE mice (<em>n</em> = 7&#x02013;8). Insulin-stimulated glucose uptake was performed from skeletal muscle (extensor digitorum longus, EDL) dissected from anesthetized mice and incubated in essential buffer (Krebs&#x02013;Henseleit, pH 7.4) and the assay was performed as described previously (<a href="#B18" rid="B18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115714">18</a>,<a href="#B19" rid="B19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115667">19</a>). *<em>P</em> &#x0003c; 0.05, NS, not significant.</p></div></div></div><p id="__p43">Furthermore, impaired glucose tolerance and insulin stimulation of Akt phosphorylation did not involve (or result in) significant changes in GLUT 2, 4 or 8 mRNA expression (determined by qPCR-microfluidic TLDA analysis, see <a href="http://nar.oxfordjournals.org/cgi/content/full/gkq180/DC1" ref="reftype=extlink&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">Supplementary Figure S7</a>). GLUT1 mRNA expression was analyzed independently by qPCR, and data presented as a footnote in <a href="http://nar.oxfordjournals.org/cgi/content/full/gkq180/DC1" ref="reftype=extlink&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">Supplementary Figure S8</a>. The expression of the mRNAs encoding Glut1, 4 and 8 was decreased by &#x0223c;20%, however, after Bayes and FDR analysis, these changes did not attain significance (<a href="http://nar.oxfordjournals.org/cgi/content/full/gkq180/DC1" ref="reftype=extlink&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">Supplementary Figure S8</a>).
</p><p id="__p45">In the context of the hyperglycemia, impaired glucose tolerance and insulin stimulation of Akt phosphorylation, we investigated whether <em>ex vivo</em> glucose uptake was affected by transgenic ROR&#x00394;DE expression. (<a href="/pmc/articles/PMC2910057/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4</span></a>E). In wild-type type 2 (fast twitch glycolytic EDL, <a href="/pmc/articles/PMC2910057/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4</span></a>E) skeletal muscle, glucose uptake was increased &#x0223c;2-fold by insulin treatment. Similar results were observed in soleus muscle (data not shown). In contrast, in the Tg-ROR&#x003b1;1&#x00394;DE mice, glucose uptake did not significantly respond to insulin treatment (<a href="/pmc/articles/PMC2910057/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4</span></a>E).</p><p id="__p46">To further explore the molecular basis of aberrant Akt2 mRNA, protein and phospho AKt expression in the transgenic Tg-ROR&#x003b1;1&#x00394;DE mice, we examined the mouse Akt2 promoter sequence (as reported on the Ensembl site) for putative RORE elements. Interestingly, we identified three putative ROR response elements (RORREs) between nucleotide positions, &#x02212;2900 to &#x02212;2600 bp upstream of the transcription start site that were concordant with the optimal ROR&#x003b1;1 binding site, <img alt="An external file that holds a picture, illustration, etc.&#10;Object name is gkq180i1.jpg" src="/pmc/articles/PMC2910057/bin/gkq180i1.jpg" class="equation" />RGGTCA as described by Giguere et al., (<a href="#B26" rid="B26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115693">26</a>). (<a href="/pmc/articles/PMC2910057/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Figure 5</span></a>A and B). In order to determine whether ROR&#x003b1; was selectively recruited to the putative ROR responsive elements (NR1, 2 and 3) within the mouse Akt2 promoter, we designed three sets of primers and one set of negative primers downstream of the putative sites within the promoter (<a href="/pmc/articles/PMC2910057/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Figure 5</span></a>) for ChIP in skeletal muscle cells. It was observed that the ROR&#x003b1; antibody [using anti-RORalpha (Santa Cruz anti-ROR&#x003b1; sc-6062)] effectively immunoprecipitated the NR1 (&#x02212;2859/&#x02212;2853) and NR2 (&#x02212;2655/&#x02212;2649 [and to a lesser extent the NR3 (&#x02212;2626/2620)] motifs relative to IgG, and the no antibody controls (<a href="/pmc/articles/PMC2910057/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Figure 5</span></a>C). The specificity of RORalpha recruitment to these NR half sites was underscored by the lack of recruitment, i.e. the failure to immunoprecipitate the negative control region further downstream between nucleotide positions &#x02212;278/&#x02212;177 [&#x0223c;1.6-kb downstream of these putative RORE sites, (<a href="/pmc/articles/PMC2910057/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Figure 5</span></a>C)]. In summary, these data clearly demonstrate that ROR&#x003b1; is recruited directly to the mouse Akt2 promoter, and suggest the direct functional involvement of ROR&#x003b1;1 in the regulation of AKt2 expression.
</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F5" co-legend-rid="lgnd_F5"><a href="/pmc/articles/PMC2910057/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140662073106192" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2910057_gkq180f5.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is gkq180f5.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2910057/bin/gkq180f5.jpg" /></a></div><div id="largeobj_idm140662073106192" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2910057/figure/F5/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F5"><div><a class="figpopup" href="/pmc/articles/PMC2910057/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5">Figure 5.</a></div><!--caption a7--><div class="caption"><p id="__p47">(<strong>A</strong>) and (<strong>B</strong>) ROR&#x003b1;1 is recruited to the Akt2 promoter. Diagrammatic representation of predicted RORalpha response elements in [concordance with the optimal ROR&#x003b1;1 binding site, (<img alt="An external file that holds a picture, illustration, etc.&#10;Object name is gkq180i2.jpg" src="/pmc/articles/PMC2910057/bin/gkq180i2.jpg" class="equation" />RGGTCA) as described by Giguere <em>et al.</em> (<a href="#B26" rid="B26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115723">26</a>)] on the promoter of mouse Akt2. Nucleotide numbering is based on the sequence and start site as reported on the ensemble web site (<a href="http://www.ensembl.org/Mus_musculus/Gene/Sequence?g" ref="reftype=extlink&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">http://www.ensembl.org/Mus_musculus/Gene/Sequence?g</a>=ENSMUSG00000004056). The nucleotide positions and sequence for NR sites 1&#x02013;3 for is shown on <a href="/pmc/articles/PMC2910057/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Figure 5</span></a>A. The downstream negative control was located between nucleotide positions &#x02013;278/&#x02013;177 (&#x0223c;1.6 kb downstream of these putative RORE sites). (<strong>C</strong>) The recruitment of ROR&#x003b1;l onto the AKt2 promoter in C2C12 myotubes by ChIP assay (representative assay) using anti-ROR&#x003b1; (Santa Cruz anti-ROR&#x003b1; sc-6062). Triplicate real-time PCR analysis was performed and the results are expressed, as the mean &#x000b1; SD. Results are representative of two independent experiments.</p></div></div></div><p id="__p48" class="p p-last">In summary, parallel analysis by illumina, ingenuity, qPCR and western and metabolic analysis has demonstrated that ROR&#x003b1; expression in skeletal muscle regulates Akt expression (and phosphorylation state), blood glucose levels, glucose tolerance and insulin-stimulated Akt2 phosphorylation and glucose uptake.</p></div><div id="__sec19" class="sec"><h3>Reduced Akt correlates with increased levels of phospho (thr172)-adenosine monophosphate kinase in Tg-ROR&#x003b1;1&#x00394;DE mice</h3><p id="__p49" class="p p-first">Recent research has demonstrated that Akt2/PKB is a potent negative regulator of AMPK activity (<a href="/pmc/articles/PMC2910057/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Figure 6</span></a>
A) in murine cardiac muscle and fibroblasts (<a href="#B27" rid="B27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115673">27</a>,<a href="#B28" rid="B28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115699">28</a>). Secondly, ingenuity interrogation of the illumina data identified AMPK signaling as a significantly regulated pathway. Therefore, we undertook western analysis of the basal and phosphorylated AMPK species (<a href="/pmc/articles/PMC2910057/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Figure 6</span></a>B). We detected no change in total AMPK protein levels (<a href="/pmc/articles/PMC2910057/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Figure 6</span></a>B and C). However, phosphorylated T172 AMPK levels were significantly elevated in skeletal muscle from Tg-ROR&#x003b1;1&#x00394;DE mice (<a href="/pmc/articles/PMC2910057/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Figure 6</span></a>B and C). The increased levels of phospho-AMPK are entirely consistent with reduced Akt2 activity.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F6" co-legend-rid="lgnd_F6"><a href="/pmc/articles/PMC2910057/figure/F6/" target="figure" rid-figpopup="F6" rid-ob="ob-F6"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140662109710368" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2910057_gkq180f6.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is gkq180f6.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2910057/bin/gkq180f6.jpg" /></a></div><div id="largeobj_idm140662109710368" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2910057/figure/F6/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F6"><div><a class="figpopup" href="/pmc/articles/PMC2910057/figure/F6/" target="figure" rid-figpopup="F6" rid-ob="ob-F6">Figure 6.</a></div><!--caption a7--><div class="caption"><p id="__p50">(<strong>A</strong>) A pictorial representation of the cross-talk between Akt2 and AMPK pathways, highlighting the implications for lipogenesis in skeletal muscle. (<strong>B</strong>) and (<strong>C</strong>) Western blot and densitometry analysis of AMPK and pAMPK in skeletal muscle of transgenic ROR&#x003b1;1&#x00394;DE and wt littermate control mice. (<strong>D</strong>) and (<strong>E</strong>) Western blot and densitometry analysis of AMPK and pAMPK in skeletal muscle of wt and staggerer (sg/sg) littermate control mice. (<em>n</em> = 3&#x02013;4/group, mean &#x000b1; SEM, *<em>P</em> &#x0003c; 0.05, **<em>P</em> &#x02264; 0.01).</p></div></div></div><p id="__p51" class="p p-last">We further investigated the levels of the basal and phosphorylated AMPK species AMPK in homozygous staggerer (sg/sg) mice that lack ROR&#x003b1; in all tissues (in contrast, to the muscle-specific overexpression of the dominant negative). We detected a slight but significant &#x0223c;1.5-fold increase in total AMPK protein levels (<a href="/pmc/articles/PMC2910057/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Figure 6</span></a>D and E) in sg/sg mice relative to wt littermates. However, the levels of phosphorylated T172 AMPK levels did not change in the skeletal muscle tissue from the sg/sg mice relative to wt littermates (<a href="/pmc/articles/PMC2910057/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Figure 6</span></a>D and E). In summary, transgenic and muscle-specific overexpression of ROR&#x003b1;1&#x00394;DE leads to elevated levels of phospho-AMPK.</p></div><div id="__sec20" class="sec"><h3>Elevated phospho-AMPK in Tg-ROR&#x003b1;1&#x00394;DE mice leads to increased phosphoACC Levels, and increased PGC-1&#x003b1; and CPT-1b mRNA expression</h3><p id="__p52" class="p p-first">The literature reports that the positive effect of activated AMPK on fatty acid oxidation is mediated by phosphorylation of Acetyl CoA carboxylase ACC (and decreased production of malonyl CoA) (see <a href="/pmc/articles/PMC2910057/figure/F7/" target="figure" class="fig-table-link figpopup" rid-figpopup="F7" rid-ob="ob-F7" co-legend-rid="lgnd_F7"><span>Figure 7</span></a>A). Moreover, AMPK activators increase the expression of PGC-1&#x003b1; and PPAR&#x003b1; target genes, for example CPT-1 in skeletal muscle (<a href="#B29" rid="B29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115722">29</a>,<a href="#B30" rid="B30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115690">30</a>). Consequently, we were particularly interested to assess whether increased expression of activated AMPK resulted in the induction of phosphoACC (Ser79) and two critical genes associated with fatty acid oxidation in the skeletal muscle of the Tg-ROR&#x003b1;1&#x00394;DE mice.
</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F7" co-legend-rid="lgnd_F7"><a href="/pmc/articles/PMC2910057/figure/F7/" target="figure" rid-figpopup="F7" rid-ob="ob-F7"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140662108898832" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2910057_gkq180f7.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is gkq180f7.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2910057/bin/gkq180f7.jpg" /></a></div><div id="largeobj_idm140662108898832" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2910057/figure/F7/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F7"><div><a class="figpopup" href="/pmc/articles/PMC2910057/figure/F7/" target="figure" rid-figpopup="F7" rid-ob="ob-F7">Figure 7.</a></div><!--caption a7--><div class="caption"><p id="__p53">(<strong>A</strong>) A pictorial representation of the cross-talk between the AMPK and fatty acid oxidation pathways, highlighting the implications for fatty acid oxidation in skeletal muscle. (<strong>B</strong>) Western blot analysis of ACC and pACC in skeletal muscle of transgenic and wt littermate control mice. Densitometry analysis of western blots (<em>n</em> = 3/group, mean &#x000b1; SEM, **<em>P</em> &#x02264; 0.01). (<strong>C</strong>) densitometry analysis of ACC and pACC in skeletal muscle of transgenic ROR&#x003b1;1&#x00394;DE and wt littermate control mice. (<strong>D</strong>) qPCR of PGC-1&#x003b1; and (<strong>E</strong>) CPT1b in skeletal muscle of transgenic and wt littermate control mice. Relative fold change is normalized against 18S mRNA (<em>n</em> = 6/group, mean &#x000b1; SEM. *<em>P</em> &#x0003c; 0.05, **<em>P</em> &#x02264; 0.01).</p></div></div></div><p id="__p54" class="p p-last">We undertook analysis of the basal and phosphorylated ACC species (<a href="/pmc/articles/PMC2910057/figure/F7/" target="figure" class="fig-table-link figpopup" rid-figpopup="F7" rid-ob="ob-F7" co-legend-rid="lgnd_F7"><span>Figure 7</span></a>B). We detected a significant change in total ACC protein levels (<a href="/pmc/articles/PMC2910057/figure/F7/" target="figure" class="fig-table-link figpopup" rid-figpopup="F7" rid-ob="ob-F7" co-legend-rid="lgnd_F7"><span>Figure 7</span></a>B). More importantly, phosphorylated ACC levels (detected by western blot) were significantly elevated in skeletal muscle from Tg-ROR&#x003b1;1&#x00394;DE mice (<a href="/pmc/articles/PMC2910057/figure/F7/" target="figure" class="fig-table-link figpopup" rid-figpopup="F7" rid-ob="ob-F7" co-legend-rid="lgnd_F7"><span>Figure 7</span></a>B and C). qPCR analysis revealed the significant (differential) expression of the mRNAs encoding PGC-1&#x003b1; (<a href="/pmc/articles/PMC2910057/figure/F7/" target="figure" class="fig-table-link figpopup" rid-figpopup="F7" rid-ob="ob-F7" co-legend-rid="lgnd_F7"><span>Figure 7</span></a>D) and CPT-1b (<a href="/pmc/articles/PMC2910057/figure/F7/" target="figure" class="fig-table-link figpopup" rid-figpopup="F7" rid-ob="ob-F7" co-legend-rid="lgnd_F7"><span>Figure 7</span></a>E) in the skeletal muscle of male Tg-ROR&#x003b1;1&#x00394;DE mice relative to wild-type littermates. The elevated levels of pACC and PGC-1&#x003b1; and CPT-1 mRNA expression in the Tg mice are consistent with increased levels of pAMPK and pACC.</p></div><div id="__sec21" class="sec sec-last"><h3>Expression of the truncated orphan nuclear receptor, ROR&#x003b1;1 had minimal effects on important skeletal muscle markers of fiber type and muscle mass</h3><p id="__p55" class="p p-first-last">We utilized qPCR-TLDA analysis to assess whether the expression of the truncated receptor affect markers of contractile function, fiber type and muscle mass (see <a href="/pmc/articles/PMC2910057/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>, <a href="http://nar.oxfordjournals.org/cgi/content/full/gkq180/DC1" ref="reftype=extlink&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">Supplementary Figure S9</a>). Specifically, in this context, TLDA analysis revealed significant differential expression of the mRNAs encoding histone deacetylase 5 (HDAC5), transforming growth factor beta receptor 1 (Tgfbr1) and several other genes (including Mef2a/d, Tnni2 and Acvr2A) in the skeletal muscle of male Tg-ROR&#x003b1;1&#x00394;DE mice relative to wild-type littermates (see <a href="/pmc/articles/PMC2910057/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>, <a href="http://nar.oxfordjournals.org/cgi/content/full/gkq180/DC1" ref="reftype=extlink&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">Supplementary Figure S9</a>) when normalized against 18S rRNA. However, following the application of conservative data filtering using the FDR&#x02013;Benjamini&#x02013;Hochberg algorithm, only HDAC5 (&#x0223c;1.25-fold) and Tgfbr1 (2.5-fold) survived as significant (but weak) decreases in expression (<a href="/pmc/articles/PMC2910057/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>, and <a href="http://nar.oxfordjournals.org/cgi/content/full/gkq180/DC1" ref="reftype=extlink&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">Supplementary Figure S9</a>). This suggested that the changes in glucose tolerance, insulin signaling and lipogenesis were not indirect effects of changes in muscle mass and/or contractile function.</p></div></div><div id="__sec22" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec22title" style="text-transform: uppercase;">DISCUSSION</h2><p id="__p56" class="p p-first">The biochemical and molecular characterization of RORs in cell culture and animal models has revealed that RORs play a critical role in the modulation of lipid homeostasis in a tissue-specific manner (<a href="#B1" rid="B1 B2 B3 B4 B5" class=" bibr popnode">1&#x02013;5</a>,<a href="#B31" rid="B31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115675">31</a>,<a href="#B32" rid="B32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115688">32</a>). Our previous studies reported that homozygous (male and female) <em>staggerer</em> mice (with decreased and dysfunctional expression of ROR&#x003b1; in all organs) display reduced adiposity and are resistant to high-fat diet-induced obesity. The lean phenotype of staggerer mice was associated with significantly increased expression of genes involved in fatty acid oxidation (including PGC-1, lipin1, etc.), and significantly reduced expression of SREBP-1c (and several lipogenic genes) in all major metabolic tissues.</p><p id="__p57">Surprisingly, studies investigating the role of ROR&#x003b1; in the regulation of glucose homeostasis have not been reported. In this context, we were particularly interested in exploring the role of ROR&#x003b1;1 in skeletal muscle, a major mass peripheral tissue that accounts for the majority of glucose disposal and lipid catabolism. We probed the role of ROR&#x003b1; signaling in this major mass peripheral tissue, by the skeletal muscle-specific overexpression of truncated ROR&#x003b1;1&#x00394;DE (lacking the ligand-binding domain) to investigate the contribution of this peripheral tissue to the ROR&#x003b1; phenotype. This construct has been described to operate in a dominant negative manner in several reports (<a href="#B21" rid="B21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115729">21</a>,<a href="#B22" rid="B22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115706">22</a>). This strategy also allows the probing of ROR&#x003b1;-dependent gene expression in the absence of an identified native and/or synthetic ligand.</p><p id="__p58">The human skeletal &#x003b1;-actin promoter was utilized to construct the muscle-specific vector. This promoter has been demonstrated to function in a cell/tissue-specific manner (<a href="#B10" rid="B10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115687">10</a>,<a href="#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115717">11</a>). As expected the transgene, ROR&#x003b1;1&#x00394;DE, was efficiently and specifically expressed in skeletal muscle of transgenic mice relative to other organ/tissues. Second, our ROR&#x003b1;1&#x00394;DE expression vector retains the native ROR&#x003b1;1 amino-terminal AF-1 domain (i.e. AB region) and the native zinc finger region; these properties ensure that the NR targets the native ROR&#x003b1;1 response elements in the skeletal muscle of transgenic mice. Giguere <em>et al.</em> (<a href="#B26" rid="B26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115711">26</a>) demonstrated that each ROR isoform displays isoform-specific DNA binding, and the amino-terminal domain and the zinc finger region work in parallel to confer sequence-specific DNA recognition and binding.</p><p id="__p59">Expression profiling, coupled to analysis on the ingenuity platform identified a ROR&#x003b1;1-regulated subset of genes that were involved in or associated with lipid metabolism, small molecule transport and biochemistry, cardiovascular and metabolic disease, carbohydrate metabolism, endocrine system disorders etc. This is in concordance with investigations in ROR&#x003b1;-deficient mouse models and <em>in vitro</em> promoter/cell culture investigations that have demonstrated the involvement of ROR&#x003b1; in a number of physiological process including atherosclerosis, lipid homeostasis, fat deposition, obesity, inflammation, immunity, etc (<a href="#B6" rid="B6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115677">6</a>). In the framework of this investigation, the primary signaling pathways regulated in skeletal muscle were glutathione metabolism (that tightly controls ROS levels and modulates insulin sensitivity), type 2 diabetic signallng and fatty acid biosynthesis. Notably, the LXR signaling (and RXR dependent) pathway was identified in the analysis, which controls lipogenesis and cholesterol homeostasis.</p><p id="__p60">In concordance with the array analysis, qPCR analysis on the TLDA platform revealed significantly attenuated expression of the mRNAs (encoding the hierarchical regulators of lipogenesis), LXR&#x003b1; and SREBP-1c and several other downstream target genes involved in fatty acid biosynthesis in skeletal muscle. For example, we observed decreased expression of the downstream target genes, SCD1 and FAS. Moreover, in the context of lipogenesis, we observed the suppression of Ascl4, Dgat2, Tip47, HIF-1 and Cd36. Acsl4, the long chain acyl CoA synthetase, plays an important role in lipid metabolism by routing fatty acids to several different metabolic pools. Decreased Acsl4 expression is associated with decreased triglycerides and fatty acids partitioning to di- and tri-acyl glycerol (<a href="#B33" rid="B33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115730">33</a>,<a href="#B34" rid="B34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115660">34</a>) and consistent with reduced Dgat2 (that catalyzes the final step in triglyceride production) and Tip47 (a perilipin family member that co-ordinates the storage of triacylglycerol (<a href="#B35" rid="B35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115692">35</a>). Furthermore, it has been reported that decreased Dgat2 expression is associated with reduced expression of SREBP-1c and SCD-1 and increased CPT-1 expression (see below), in concordance with our observations (<a href="#B36" rid="B36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115686">36</a>). Finally, suppression of HIF-1alpha is associated with reduced fatty acid uptake and biosynthesis, and in concordance with the suppression of the genetic program controlling lipogenesis and the decrease in the fatty acid translocase, CD36 (<a href="#B37" rid="B37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115684">37</a>).</p><p id="__p61">In the context of the decrease in LXR and other NR signaling pathways, we completed TLDA analysis of the entire NR supergene family. This analysis identified decreases in the expression of the mRNAs encoding GR, PPAR&#x003b4;, TR2 and ROR&#x003b3;. These nuclear receptors have been implicated in the regulation of lipid homeostasis. We did not observe decreases in THR(&#x003b1; / &#x003b2;), FXR, VDR, etc. that were identified by ingenuity. We suggest that the detection of these pathways by ingenuity reflects secondary consequences of ROR&#x003b1;-mediated dysregulation and the aberrant expression of NRs identified above.</p><p id="__p62">As discussed, ingenuity analysis of the array data identified carbohydrate metabolism as a significantly regulated function. We observed the male tg-ROR&#x003b1;1&#x00394;DE mice display significantly increased fasting plasma glucose levels, impaired glucose tolerance and attenuated insulin-stimulated glucose uptake relative to wild-type littermates. Our qPCR TLDA profiling identified the significantly decreased expression of the mRNA encoding Akt2/PKB in skeletal muscle, after Bayes assignment of significance and stringent FDR filtering. Furthermore, the total amount of Akt and phospho-Akt protein was significantly reduced. In this context, several studies have demonstrated that, Akt2 plays a critical role in insulin-mediated glucose disposal in skeletal muscle. For example, Cho <em>et al.</em> (<a href="#B38" rid="B38" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115694">38</a>) demonstrated that disruption of the Akt2 gene expression in mice was associated with insulin resistance and type2 diabetes-like syndrome. Subsequently, Garofalo <em>et al.</em> (<a href="#B39" rid="B39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115713">39</a>) showed mice lacking Akt2/PKB gene displayed a diabetic phenotype and age-dependant lipodystrophy.</p><p id="__p63">Interestingly, the mild hyperglycemia (in the fasted state), glucose intolerance and impaired glucose uptake occur without any significant change in whole body insulin sensitivity (i.e. the insulin tolerance test) and/or change in GLUT1 and four expression. First, this does not appear to involve an insulin secretion defect as the transgene is not expressed in the pancreas and the mice develop hyperinsulinemia after a high-fat challenge (data not shown). It should be noted that muscle-specific deletion of an essential component (rictor) of the mTOR complex 2 leads to the attenuation of insulin-induced phosphorylation of Akt2 at Ser473. Moreover, these mice displayed glucose intolerance, however, insulin sensitivity remained unchanged (<a href="#B40" rid="B40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115668">40</a>). Similarly, our Tg-ROR&#x003b1;1&#x00394;DE mice displayed an attenuated insulin-mediated Ser473 phosphorylation of Akt and glucose uptake. In this context, Gonzalez and McGraw (<a href="#B41" rid="B41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115718">41</a>) demonstrated that &#x02018;insulin signalling diverges into Akt-dependent and independent signals&#x02019;. James and colleagues (<a href="#B42" rid="B42" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625065027">42</a>) recently stated that several studies underscore the pivotal role of Akt2 in GLUT4 function; however, many gaps remain in understanding the signaling cascades involved. For example, similar inconsistencies (between impaired glucose uptake and/or normal glucose tolerance and insulin sensitivity) have been described in other animal models that have perturbed expression and/or knockout in critical genes that regulate glucose homeostasis.</p><p id="__p64">ChIP analysis revealed ROR&#x003b1;l was directly involved in the regulation of Akt2. We identified several potential RORa1 response elements in the mouse Akt2 promoter between &#x02212;2900 and &#x02212;2600 nt upstream of the transcription start site. These sites were accommodated by the motif <img alt="An external file that holds a picture, illustration, etc.&#10;Object name is gkq180i3.jpg" src="/pmc/articles/PMC2910057/bin/gkq180i3.jpg" class="equation" />RGGTCA described by Giguere <em>et al.</em> (<a href="#B26" rid="B26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115719">26</a>), as an optimal ROR&#x003b1;1-binding site. ChIP identified functional ROR&#x003b1;1 recruitment to three sites (in close proximity) within this region. Further characterization of the Akt2 promoter is required to elucidate the mechanism mediating regulation by ROR&#x003b1;1.</p><p id="__p65">Ingenuity identified AMPK signaling as a regulated pathway in the Tg mice overexpressing the dominant negative ROR&#x003b1;1. It has been well established that AMPK is master regulator of energy homeostasis through the suppression of ATP-consuming lipogenic pathways and by the enhancement of ATP producing catabolic pathways, including fatty acid oxidation in skeletal muscle tissue (43,44 and references therein). Moreover, Akt2/PKB is a potent modulator of AMPK activity. For example, Hahn-Windgassen <em>et al.</em> (<a href="#B28" rid="B28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115683">28</a>) showed that Akt/PKB regulates intracellular ATP levels through regulating AMPK activity. Furthermore, Planavila <em>et al.</em> (<a href="#B45" rid="B45" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115732">45</a>) showed that mice treated with troglitazone (PPAR&#x003b3; agonist) in skeletal muscle were associated with increased Akt2/PKB and decreased AMPK activity. Moreover, recent investigations on Akt2/PKB and AMPK pathways in heart tissue showed that Akt2/PKB is a negative regulator of AMPK activity (<a href="#B27" rid="B27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115733">27</a>). Finally, the association between increased AMPK activity and the reduction of lipogenic gene expression and genes regulating fatty acid oxidation is well documented (<a href="#B46" rid="B46 B47 B48 B49" class=" bibr popnode">46&#x02013;49</a>). Furthermore, the inhibitory effect of potent AMPK activators such as aminoimidazole carboxamide ribonucleotide (AICAR) or Metformin on lipogenesis in skeletal muscle has been described in both human and rodents (<a href="#B29" rid="B29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115679">29</a>,<a href="#B30" rid="B30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115659">30</a>). Consequently, in the context of our studies, we were particularly interested in examining the cross-talk between lipid homeostasis (lipogenesis and fatty acid oxidation), Akt2 signaling (and glucose tolerance) and AMPK signaling in a background of aberrant ROR&#x003b1;1 (NR) signaling.</p><p id="__p66">Interestingly, the hyperglycemia and significantly decreased Akt2 (mRNA and protein) and phosphoAKT levels in the Tg-ROR&#x003b1;1&#x00394;DE mice are associated with increased phosphoAMPK levels, in concordance with the studies discussed above. This is consistent with studies demonstrating type 2 diabetic patients also display normal AMPK signaling (<a href="#B50" rid="B50" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115672">50</a>,<a href="#B51" rid="B51" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115735">51</a>). Paradoxically, some studies report that increased AMPK activity mediates (only exercise induced) glucose transport. However, AMPK null mice exhibit typical exercise stimulated glucose uptake in skeletal muscle and AICAR does not induce glucose transport in muscle (<a href="#B52" rid="B52" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115670">52</a>). Interestingly, we did not observe increases in pAMPK in the skeletal muscle of <em>staggerer</em> (sg/sg) mice that lack ROR&#x003b1; expression in all tissues (although we observed mild elevation in the levels of basal/total AMPK). Differential AMPK activity in these lines is not completely unexpected for several reasons. Firstly, we are comparing a line of mice overexpressing dominant negative RORa1 (in skeletal muscle), against a line of mice lacking ROR&#x003b1;1 expression. Second, in mice lacking NR expression, genes (and/or phenotypes) maybe silenced or derepressed depending on cofactor requirements, expression and/or promoter characteristics (<a href="#B53" rid="B53" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115682">53</a>).</p><p id="__p67">The increased AMPK activity in the Tg-ROR&#x003b1;1&#x00394;DE mice did not only correlate with decreased Akt activity, but was also consistent with (i) attenuated mRNA expression of LXR&#x003b1; and SREBP-1c, and several other genes involved in fatty acid biosynthesis in skeletal muscle (<a href="#B44" rid="B44" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115727">44</a>,<a href="#B54" rid="B54" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115704">54</a>,<a href="#B55" rid="B55" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115696">55</a>) and (ii) induction of the genes/pathways increasing fatty acid oxidation (<a href="#B56" rid="B56" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115703">56</a>). For example, SCD1 deficiency has been reported to be associated with increased AMPK activity, fatty acid oxidation and reduced ceramide synthesis (<a href="#B41" rid="B41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115737">41</a>,<a href="#B42" rid="B42" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625065028">42</a>,<a href="#B57" rid="B57" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_362115734">57</a>). In addition, in this interconnected regulatory milieu, we observed increased expression of two critical regulators of fatty acid oxidation, PGC-1&#x003b1; and CPT1b, concomitant with elevated levels of phospho-Ser79 ACC in the Tg-ROR&#x003b1;1&#x00394;DE mice, relative to the wt littermate mice. This is also consistent with the observations (47&#x02013;49,56 and references therein) that activated AMPK and AMPK agonists regulate PGC-1 and pACC expression.</p><p id="__p68">Finally, overexpression of truncated ROR&#x003b1; in skeletal muscle resulted in very minor changes in the expression of genes regulating muscle mass, proliferation and differentiation. Interestingly, the analysis did identify HDAC5 as a differentially expressed gene. A recent study has demonstrated the link between AMPK, energy balance and transcriptional regulation of GLUT4 expression mediated by HDAC5. That study indicated that increased AMPK activity induced HDAC phosphorylation that reduces HDAC5 association with the GLUT4 promoter. Interestingly, in our mouse model, although insulin mediated phosphorylation of Akt2, and glucose uptake was perturbed; the association between increased AMPK activity and HDAC5 was maintained.</p><p id="__p69" class="p p-last">In conclusion our investigation reveals that the orphan nuclear receptor ROR&#x003b1; operates at the nexus of pathways controlling the association between lipid homeostasis (lipogenesis, and fatty acid oxidation), Akt2 signaling (glucose tolerance and uptake) and AMPK signaling.</p></div><div id="__sec23" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec23title" style="text-transform: uppercase;">SUPPLEMENTARY DATA</h2><p id="__p70" class="p p-first-last"><a href="http://nar.oxfordjournals.org/cgi/content/full/gkq180/DC1" ref="reftype=extlink&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">Supplementary Data</a> are available at NAR Online.</p></div><div id="__sec24" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec24title" style="text-transform: uppercase;">FUNDING</h2><p id="__p71" class="p p-first">Research project grant from the National Health and Medical Research Council (NHMRC) of Australia, and the Diabetes Australia Research Trust (DART). GEOM is a Principal Research Fellow of the NHMRC, and Suryaprakash Raichur was a recipient of an International Postgraduate Research Scholarship (IPRS).</p><p id="__p72" class="p p-last"><em>Conflict of interest statement</em>. None declared.</p></div><div id="__sec25" class="tsec sec"><a id="supplementary-material-sec"></a><h2 class="head no_bottom_margin" id="__sec25title" style="text-transform: uppercase;">Supplementary Material</h2><!--/article/body/sec/--><div class="sec suppmat" id="PMC_1">

<!--caption a9--><strong>[Supplementary Data]</strong>

<div class="sup-box half_rhythm"><a href="/pmc/articles/PMC2910057/bin/gkq180_index.html">Click here to view.</a></div>

</div></div><div id="idm140662066809600" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140662066809600title" style="text-transform: uppercase;">REFERENCES</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="B1">1. <span class="element-citation">Raspe E, Duez H, Gervois P, Fievet C, Fruchart JC, Besnard S, Mariani J, Tedgui A, Staels B. Transcriptional regulation of apolipoprotein C-III gene expression by the orphan nuclear receptor RORalpha. <span><span class="ref-journal">J. Biol. Chem. </span>2001;<span class="ref-vol">276</span>:2865–2871.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/11053433" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B2">2. <span class="element-citation">Mamontova A, Seguret-Mace S, Esposito B, Chaniale C, Bouly M, Delhaye-Bouchaud N, Luc G, Staels B, Duverger N, Mariani J, et al.  Severe atherosclerosis and hypoalphalipoproteinemia in the staggerer mouse, a mutant of the nuclear receptor RORalpha. <span><span class="ref-journal">Circulation. </span>1998;<span class="ref-vol">98</span>:2738–2743.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/9851961" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B3">3. <span class="element-citation">Lau P, Nixon SJ, Parton RG, Muscat GE. RORalpha regulates the expression of genes involved in lipid homeostasis in skeletal muscle cells: caveolin-3 and CPT-1 are direct targets of ROR. <span><span class="ref-journal">J. Biol. Chem. </span>2004;<span class="ref-vol">279</span>:36828–36840.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/15199055" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B4">4. <span class="element-citation">Raichur S, Lau P, Staels B, Muscat GE. Retinoid-related orphan receptor gamma regulates several genes that control metabolism in skeletal muscle cells: links to modulation of reactive oxygen species production. <span><span class="ref-journal">J. Mol. Endocrinol. </span>2007;<span class="ref-vol">39</span>:29–44.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/17601883" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B5">5. <span class="element-citation">Vu-Dac N, Gervois P, Grotzinger T, De Vos P, Schoonjans K, Fruchart JC, Auwerx J, Mariani J, Tedgui A, Staels B. Transcriptional regulation of apolipoprotein A-I gene expression by the nuclear receptor RORalpha. <span><span class="ref-journal">J Biol. Chem. </span>1997;<span class="ref-vol">272</span>:22401–22404.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/9278389" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B6">6. <span class="element-citation">Jetten AM. Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism. <span><span class="ref-journal">Nucl. Recept. Signal. </span>2009;<span class="ref-vol">7</span>:e003.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2670432/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/19381306" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B7">7. <span class="element-citation">Kang HS, Angers M, Beak JY, Wu X, Gimble JM, Wada T, Xie W, Collins JB, Grissom SF, Jetten AM. Gene expression profiling reveals a regulatory role for ROR alpha and ROR gamma in phase I and phase II metabolism. <span><span class="ref-journal">Physiol. Genomics. </span>2007;<span class="ref-vol">31</span>:281–294.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/17666523" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B8">8. <span class="element-citation">Lau P, Fitzsimmons RL, Raichur S, Wang SC, Lechtken A, Muscat GE. The orphan nuclear receptor, ROR{alpha}, regulates gene expression that controls lipid metabolism: STAGGERER (SG/SG) mice are resistant to diet-induced obesity. <span><span class="ref-journal">J. Biol. Chem. </span>2008;<span class="ref-vol">283</span>:18411–18421.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/18441015" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B9">9. <span class="element-citation">Schmitz-Peiffer C. Signalling aspects of insulin resistance in skeletal muscle: mechanisms induced by lipid oversupply. <span><span class="ref-journal">Cell Signal. </span>2000;<span class="ref-vol">12</span>:583–594.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/11080610" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B10">10. <span class="element-citation">Brennan KJ, Hardeman EC. Quantitative analysis of the human alpha-skeletal actin gene in transgenic mice. <span><span class="ref-journal">J. Biol. Chem. </span>1993;<span class="ref-vol">268</span>:719–725.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/7678010" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B11">11. <span class="element-citation">Muscat GE, Kedes L. Multiple 5&#x02032;-flanking regions of the human alpha-skeletal actin gene synergistically modulate muscle-specific expression. <span><span class="ref-journal">Mol. Cell Biol. </span>1987;<span class="ref-vol">7</span>:4089–4099.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC368080/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/2828926" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B12">12. <span class="element-citation">Wang YX, Zhang CL, Yu RT, Cho HK, Nelson MC, Bayuga-Ocampo CR, Ham J, Kang H, Evans RM. Regulation of muscle fiber type and running endurance by PPARdelta. <span><span class="ref-journal">PLoS Biol. </span>2004;<span class="ref-vol">2</span>:e294.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC509410/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/15328533" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B13">13. <span class="element-citation">Jaenisch R. Transgenic animals. <span><span class="ref-journal">Science. </span>1988;<span class="ref-vol">240</span>:1468–1474.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/3287623" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B14">14. <span class="element-citation">Mitrecic D, Huzak M, Curlin M, Gajovic S. An improved method for determination of gene copy numbers in transgenic mice by serial dilution curves obtained by real-time quantitative PCR assay. <span><span class="ref-journal">J. Biochem. Biophys. Methods. </span>2005;<span class="ref-vol">64</span>:83–98.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/15985294" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B15">15. <span class="element-citation">Bookout AL, Jeong Y, Downes M, Yu RT, Evans RM, Mangelsdorf DJ. Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. <span><span class="ref-journal">Cell. </span>2006;<span class="ref-vol">126</span>:789–799.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16923397" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B16">16. <span class="element-citation">Yang X, Downes M, Yu RT, Bookout AL, He W, Straume M, Mangelsdorf DJ, Evans RM. Nuclear receptor expression links the circadian clock to metabolism. <span><span class="ref-journal">Cell. </span>2006;<span class="ref-vol">126</span>:801–810.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16923398" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B17">17. <span class="element-citation">Myers SA, Eriksson N, Burow R, Wang SC, Muscat GE. Beta-adrenergic signaling regulates NR4A nuclear receptor and metabolic gene expression in multiple tissues. <span><span class="ref-journal">Mol. Cell Endocrinol. </span>2009;<span class="ref-vol">309</span>:101–108.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/19465082" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B18">18. <span class="element-citation">Brozinick JT, Jr, Birnbaum MJ. Insulin, but not contraction, activates Akt/PKB in isolated rat skeletal muscle. <span><span class="ref-journal">J. Biol. Chem. </span>1998;<span class="ref-vol">273</span>:14679–14682.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/9614064" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B19">19. <span class="element-citation">Watt MJ, Dzamko N, Thomas WG, Rose-John S, Ernst M, Carling D, Kemp BE, Febbraio MA, Steinberg GR. CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK. <span><span class="ref-journal">Nat. Med. </span>2006;<span class="ref-vol">12</span>:541–548.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16604088" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B20">20. <span class="element-citation">Pearen MA, Myers SA, Raichur S, Ryall JG, Lynch GS, Muscat GE. The orphan nuclear receptor, NOR-1, a target of beta-adrenergic signaling, regulates gene expression that controls oxidative metabolism in skeletal muscle. <span><span class="ref-journal">Endocrinology. </span>2008;<span class="ref-vol">149</span>:2853–2865.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/18325999" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B21">21. <span class="element-citation">McBroom LD, Flock G, Giguere V. The nonconserved hinge region and distinct amino-terminal domains of the ROR alpha orphan nuclear receptor isoforms are required for proper DNA bending and ROR alpha-DNA interactions. <span><span class="ref-journal">Mol. Cell Biol. </span>1995;<span class="ref-vol">15</span>:796–808.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC231954/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/7823947" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B22">22. <span class="element-citation">Hamilton BA, Frankel WN, Kerrebrock AW, Hawkins TL, FitzHugh W, Kusumi K, Russell LB, Mueller KL, van Berkel V, Birren BW, et al.  Disruption of the nuclear hormone receptor RORalpha in staggerer mice. <span><span class="ref-journal">Nature. </span>1996;<span class="ref-vol">379</span>:736–739.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/8602221" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B23">23. <span class="element-citation">Clapham JC, Arch JR, Chapman H, Haynes A, Lister C, Moore GB, Piercy V, Carter SA, Lehner I, Smith SA, et al.  Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean. <span><span class="ref-journal">Nature. </span>2000;<span class="ref-vol">406</span>:415–418.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/10935638" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B24">24. <span class="element-citation">Genoux A, Dehondt H, Helleboid-Chapman A, Duhem C, Hum DW, Martin G, Pennacchio LA, Staels B, Fruchart-Najib J, Fruchart JC. Transcriptional regulation of apolipoprotein A5 gene expression by the nuclear receptor RORalpha. <span><span class="ref-journal">Arterioscler. Thromb. Vasc. Biol. </span>2005;<span class="ref-vol">25</span>:1186–1192.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/15790933" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B25">25. <span class="element-citation">Lind U, Nilsson T, McPheat J, Stromstedt PE, Bamberg K, Balendran C, Kang D. Identification of the human ApoAV gene as a novel RORalpha target gene. <span><span class="ref-journal">Biochem. Biophys. Res. Commun. </span>2005;<span class="ref-vol">330</span>:233–241.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/15781255" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B26">26. <span class="element-citation">Giguere V, Tini M, Flock G, Ong E, Evans RM, Otulakowski G. Isoform-specific amino-terminal domains dictate DNA-binding properties of ROR alpha, a novel family of orphan hormone nuclear receptors. <span><span class="ref-journal">Genes Dev. </span>1994;<span class="ref-vol">8</span>:538–553.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/7926749" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B27">27. <span class="element-citation">Kovacic S, Soltys CL, Barr AJ, Shiojima I, Walsh K, Dyck JR. Akt activity negatively regulates phosphorylation of AMP-activated protein kinase in the heart. <span><span class="ref-journal">J. Biol. Chem. </span>2003;<span class="ref-vol">278</span>:39422–39427.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/12890675" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B28">28. <span class="element-citation">Hahn-Windgassen A, Nogueira V, Chen CC, Skeen JE, Sonenberg N, Hay N. Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity. <span><span class="ref-journal">J. Biol. Chem. </span>2005;<span class="ref-vol">280</span>:32081–32089.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16027121" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B29">29. <span class="element-citation">Kola B, Boscaro M, Rutter GA, Grossman AB, Korbonits M. Expanding role of AMPK in endocrinology. <span><span class="ref-journal">Trends Endocrinol. Metab. </span>2006;<span class="ref-vol">17</span>:205–215.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16766204" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B30">30. <span class="element-citation">Osler ME, Zierath JR. Adenosine 5&#x02032;-monophosphate-activated protein kinase regulation of fatty acid oxidation in skeletal muscle. <span><span class="ref-journal">Endocrinology. </span>2008;<span class="ref-vol">149</span>:935–941.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/18202133" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B31">31. <span class="element-citation">Wada T, Kang HS, Jetten AM, Xie W. The emerging role of nuclear receptor ROR{alpha} and its crosstalk with LXR in Xeno- and endobiotic gene regulation. <span><span class="ref-journal">Exp. Biol. Med. (Maywood) </span>2008;<span class="ref-vol">233</span>:1191–1201.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2658633/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/18535165" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B32">32. <span class="element-citation">Wada T, Kang HS, Angers M, Gong H, Bhatia S, Khadem S, Ren S, Ellis E, Strom SC, Jetten AM, et al.  Identification of oxysterol 7alpha-hydroxylase (Cyp7b1) as a novel retinoid-related orphan receptor alpha (RORalpha) (NR1F1) target gene and a functional cross-talk between RORalpha and liver X receptor (NR1H3) <span><span class="ref-journal">Mol. Pharmacol. </span>2008;<span class="ref-vol">73</span>:891–899.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/18055760" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B33">33. <span class="element-citation">Askari B, Kanter JE, Sherrid AM, Golej DL, Bender AT, Liu J, Hsueh WA, Beavo JA, Coleman RA, Bornfeldt KE. Rosiglitazone inhibits acyl-CoA synthetase activity and fatty acid partitioning to diacylglycerol and triacylglycerol via a peroxisome proliferator-activated receptor-gamma-independent mechanism in human arterial smooth muscle cells and macrophages. <span><span class="ref-journal">Diabetes. </span>2007;<span class="ref-vol">56</span>:1143–1152.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2819351/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/17259370" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B34">34. <span class="element-citation">Kudo T, Tamagawa T, Kawashima M, Mito N, Shibata S. Attenuating effect of clock mutation on triglyceride contents in the ICR mouse liver under a high-fat diet. <span><span class="ref-journal">J. Biol. Rhythms. </span>2007;<span class="ref-vol">22</span>:312–323.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/17660448" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B35">35. <span class="element-citation">Ducharme NA, Bickel PE. Lipid droplets in lipogenesis and lipolysis. <span><span class="ref-journal">Endocrinology. </span>2008;<span class="ref-vol">149</span>:942–949.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/18202123" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B36">36. <span class="element-citation">Choi CS, Savage DB, Kulkarni A, Yu XX, Liu ZX, Morino K, Kim S, Distefano A, Samuel VT, Neschen S, et al.  Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance. <span><span class="ref-journal">J. Biol. Chem. </span>2007;<span class="ref-vol">282</span>:22678–22688.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/17526931" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B37">37. <span class="element-citation">Krishnan J, Suter M, Windak R, Krebs T, Felley A, Montessuit C, Tokarska-Schlattner M, Aasum E, Bogdanova A, Perriard E, et al.  Activation of a HIF1alpha-PPARgamma axis underlies the integration of glycolytic and lipid anabolic pathways in pathologic cardiac hypertrophy. <span><span class="ref-journal">Cell Metab. </span>2009;<span class="ref-vol">9</span>:512–524.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/19490906" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B38">38. <span class="element-citation">Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw E.B., 3rd, Kaestner KH, Bartolomei MS, Shulman GI, Birnbaum MJ. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta) <span><span class="ref-journal">Science. </span>2001;<span class="ref-vol">292</span>:1728–1731.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/11387480" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B39">39. <span class="element-citation">Garofalo RS, Orena SJ, Rafidi K, Torchia AJ, Stock JL, Hildebrandt AL, Coskran T, Black SC, Brees DJ, Wicks JR, et al.  Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta. <span><span class="ref-journal">J. Clin. Invest. </span>2003;<span class="ref-vol">112</span>:197–208.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC164287/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/12843127" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B40">40. <span class="element-citation">Kumar A, Harris TE, Keller SR, Choi KM, Magnuson MA, Lawrence J.C., Jr Muscle-specific deletion of rictor impairs insulin-stimulated glucose transport and enhances Basal glycogen synthase activity. <span><span class="ref-journal">Mol. Cell Biol. </span>2008;<span class="ref-vol">28</span>:61–70.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2223287/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/17967879" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B41">41. <span class="element-citation">Gonzalez E, McGraw TE. Insulin signaling diverges into Akt-dependent and -independent signals to regulate the recruitment/docking and the fusion of GLUT4 vesicles to the plasma membrane. <span><span class="ref-journal">Mol. Biol. Cell. </span>2006;<span class="ref-vol">17</span>:4484–4493.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC1635362/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16914513" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B42">42. <span class="element-citation">Larance M, Ramm G, James DE. The GLUT4 code. <span><span class="ref-journal">Mol. Endocrinol. </span>2008;<span class="ref-vol">22</span>:226–233.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC5419637/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/17717074" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B43">43. <span class="element-citation">Hegarty BD, Turner N, Cooney GJ, Kraegen EW. Insulin resistance and fuel homeostasis: the role of AMP-activated protein kinase. <span><span class="ref-journal">Acta. Physiol. (Oxf) </span>2009;<span class="ref-vol">196</span>:129–145.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/19245658" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B44">44. <span class="element-citation">Viollet B, Athea Y, Mounier R, Guigas B, Zarrinpashneh E, Horman S, Lantier L, Hebrard S, Devin-Leclerc J, Beauloye C, et al.  AMPK: lessons from transgenic and knockout animals. <span><span class="ref-journal">Front. Biosci. </span>2009;<span class="ref-vol">14</span>:19–44.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2666987/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/19273052" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B45">45. <span class="element-citation">Planavila A, Alegret M, Sanchez RM, Rodriguez-Calvo R, Laguna JC, Vazquez-Carrera M. Increased Akt protein expression is associated with decreased ceramide content in skeletal muscle of troglitazone-treated mice. <span><span class="ref-journal">Biochem. Pharmacol. </span>2005;<span class="ref-vol">69</span>:1195–1204.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/15794940" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B46">46. <span class="element-citation">Rutter GA, Da Silva Xavier G, Leclerc I. Roles of 5&#x02032;-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis. <span><span class="ref-journal">Biochem. J. </span>2003;<span class="ref-vol">375</span>:1–16.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC1223661/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/12839490" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B47">47. <span class="element-citation">Jorgensen SB, Viollet B, Andreelli F, Frosig C, Birk JB, Schjerling P, Vaulont S, Richter EA, Wojtaszewski JF. Knockout of the alpha2 but not alpha1 5&#x02032;-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle. <span><span class="ref-journal">J. Biol. Chem. </span>2004;<span class="ref-vol">279</span>:1070–1079.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/14573616" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B48">48. <span class="element-citation">Jorgensen SB, Wojtaszewski JF, Viollet B, Andreelli F, Birk JB, Hellsten Y, Schjerling P, Vaulont S, Neufer PD, Richter EA, et al.  Effects of alpha-AMPK knockout on exercise-induced gene activation in mouse skeletal muscle. <span><span class="ref-journal">FASEB J. </span>2005;<span class="ref-vol">19</span>:1146–1148.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/15878932" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B49">49. <span class="element-citation">Narkar VA, Downes M, Yu RT, Embler E, Wang YX, Banayo E, Mihaylova MM, Nelson MC, Zou Y, Juguilon H, et al.  AMPK and PPARdelta agonists are exercise mimetics. <span><span class="ref-journal">Cell. </span>2008;<span class="ref-vol">134</span>:405–415.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2706130/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/18674809" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B50">50. <span class="element-citation">Musi N, Fujii N, Hirshman MF, Ekberg I, Froberg S, Ljungqvist O, Thorell A, Goodyear LJ. AMP-activated protein kinase (AMPK) is activated in muscle of subjects with type 2 diabetes during exercise. <span><span class="ref-journal">Diabetes. </span>2001;<span class="ref-vol">50</span>:921–927.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/11334434" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B51">51. <span class="element-citation">Musi N, Hayashi T, Fujii N, Hirshman MF, Witters LA, Goodyear LJ. AMP-activated protein kinase activity and glucose uptake in rat skeletal muscle. <span><span class="ref-journal">Am. J. Physiol. Endocrinol. Metab. </span>2001;<span class="ref-vol">280</span>:E677–684.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/11287349" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B52">52. <span class="element-citation">Fujii N, Aschenbach WG, Musi N, Hirshman MF, Goodyear LJ. Regulation of glucose transport by the AMP-activated protein kinase. <span><span class="ref-journal">Proc. Nutr. Soc. </span>2004;<span class="ref-vol">63</span>:205–210.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/15294031" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B53">53. <span class="element-citation">Wagner BL, Valledor AF, Shao G, Daige CL, Bischoff ED, Petrowski M, Jepsen K, Baek SH, Heyman RA, Rosenfeld MG, et al.  Promoter-specific roles for liver X receptor/corepressor complexes in the regulation of ABCA1 and SREBP1 gene expression. <span><span class="ref-journal">Mol. Cell Biol. </span>2003;<span class="ref-vol">23</span>:5780–5789.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC166346/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/12897148" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B54">54. <span class="element-citation">Viollet B, Foretz M, Guigas B, Horman S, Dentin R, Bertrand L, Hue L, Andreelli F. Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders. <span><span class="ref-journal">J. Physiol. </span>2006;<span class="ref-vol">574</span>:41–53.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC1817784/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16644802" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B55">55. <span class="element-citation">Yang J, Craddock L, Hong S, Liu ZM. AMP-activated protein kinase suppresses LXR-dependent sterol regulatory element-binding protein-1c transcription in rat hepatoma McA-RH7777 cells. <span><span class="ref-journal">J. Cell Biochem. </span>2009;<span class="ref-vol">106</span>:414–426.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/19125418" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B56">56. <span class="element-citation">Hardie DG, Carling D, Carlson M. The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? <span><span class="ref-journal">Annu. Rev. Biochem. </span>1998;<span class="ref-vol">67</span>:821–855.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/9759505" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B57">57. <span class="element-citation">Dobrzyn A, Dobrzyn P, Lee SH, Miyazaki M, Cohen P, Asilmaz E, Hardie DG, Friedman JM, Ntambi JM. Stearoyl-CoA desaturase-1 deficiency reduces ceramide synthesis by downregulating serine palmitoyltransferase and increasing beta-oxidation in skeletal muscle. <span><span class="ref-journal">Am. J. Physiol. Endocrinol. Metab. </span>2005;<span class="ref-vol">288</span>:E599–E607.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/15562249" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2910057&amp;issue-id=188806&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr />Articles from <span class="acknowledgment-journal-title">Nucleic Acids Research</span> are provided here courtesy of <strong>Oxford University Press</strong></div></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC2910057/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC2910057/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC2910057/pdf/gkq180.pdf">PDF (1.4M)</a></li> | <li><a href="#" data-citationid="PMC2910057" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2910057%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2910057%2F&amp;text=Identification%20and%20validation%20of%20the%20pathways%20and%20functions%20regulated%20by%20the%20orphan%20nuclear%20receptor%2C%20ROR%20alpha1%2C%20in%20skeletal%20muscle"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2910057%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="20338882" data-aiid="2910057" data-aid="2910057" data-iid="188806" data-domainid="4" data-domain="nar" data-accid="PMC2910057" data-md5="ba6de9b350929e513ee52e55903a7fdd"></div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2018-07-16T19:06:14-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc202&amp;ncbi_phid=F4FC690BB4D241A100000000005C0051&amp;ncbi_session=F4FC690BB4D24E51_0092SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2910057%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=nar&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC2910057/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- F4FC690BB4D24E51_0092SID /projects/PMC/PMCViewer@4.46 ptpmc202 v4.1.r563004 Tue, May 01 2018 03:01:28 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>
</html>